41 EDTNA/ERCA - 41st EDTNA/ERCA International Conference

st 

41 EDTNA/ERCA 

INTERNATIONAL CONFERENCE 

GLOBAL ADVANCES IN RENAL CARE: 

ECONOMIC AND QUALITY IMPACT ON DISEASE MANAGEMENT 

EUROPEAN PARLIAMENT, STRASBOURG 

15 - 18 SEPTEMBER 2012 

CONVENTION CENTRE STRASBOURG, FRANCE 

FINAL PROGRAMME 

WWW.EDTNAERCA.ORG

ACKNOWLEDGEMENTS 

The organisers would like to thank the following institutions for and companies for their 

st 

generous support of the 41 EDTNA/ERCA International Conference: 

DIAMOND SPONSORS 

SILVER SPONSOR 

BRONZE SPONSORS 

OTHER SPONSORS 

UNDER THE PATRONAGE 

OF VILLE ET COMMUNAUTÉ URBAINE DE STRASBOURG

CONTENT 

ST 

41 EDTNA/ERCA 

INTERNATIONAL CONFERENCE 

Saturday 15 September to Tuesday 18 September 2012 

Strasbourg Convention and Conference Centre 

Place de Bordeaux-Wacken 

Strasbourg, France 

PAGE 

WELCOME MESSAGE ........................................................................................................................... 3 

CONFERENCE VENUE FLOORPLAN ............................................................................................................. 4 

COMMITTEES ................................................................................................................................... 5 

PROGRAMME HIGHLIGHTS ..................................................................................................................... 6 

CES - CORPORATE EDUCATION SESSIONS ................................................................................................ 8 

WORKSHOPS,LUNCH SATELLITE SYMPOSIA,ONE MINUTE MADNESS .................................................................. 10 

COUNTRY MEETINGS .................................................................................................................... 11 

POSTER SESSIONS ............................................................................................................................ 12 

POSTER AREA FLOOR PLAN ................................................................................................................. 13 

EDTNA/ERCA MANUSCRIPT SCHOLARSHIP ................................................................................................ 14 

EDTNA/ERCA PUBLICATIONS .............................................................................................................. 15 

SCIENTIFIC PROGRAMME ..................................................................................................................... 16 

POSTER SESSIONS ............................................................................................................................ 22 

EXHIBITION ................................................................................................................................... 36 

LIST OF EXHIBITORS ......................................................................................................................... 36 

EXHIBITION AREA FLOOR PLAN .............................................................................................................. 41 

PRACTICAL INFORMATION A-Z .............................................................................................................. 42 

SOCIAL EVENTS .............................................................................................................................. 45 

ABOUT EDTNA/ERCA ..................................................................................................................... 46 

KEY AND LINK MEMBERS .................................................................................................................... 47 

EDTNA/ERCA PUBLICATIONS .............................................................................................................. 50 

CORPORATE MEMBERS ....................................................................................................................... 51 

BECOME A PART OF EDTNA/ERCA COMMUNITY .......................................................................................... 52 

CONFERENCE MEMBERSHIP................................................................................................................... 

53 

A-Z INFORMATION ON ALSACE,FRANCE .................................................................................................... 54 

EDTNA/ERCA INTERNATIONAL CONFERENCE 2013 ....................................................................................... 56 

STRASBOURG CITY MAP .......................................................................................................... COVER PAGES 

ST 

41 EDTNA/ERCA INTERNATIONAL CONFERENCE | STRASBOURG, FRANCE, 15-18 SEPTEMBER 2012 

1

In case of loss, please return to: 

Notes: 

2 FINAL PROGRAMME | WWW.EDTNAERCA.ORG

WELCOME MESSAGE 

FROM THE EXECUTIVE COMMITTEE 

Dear Colleagues and Friends, 

st 

It is a greatpleasure and honor to welcome you all to the 41 EDTNA/ERCA International Conference taking place in 

th th 

Strasbourg, France, on the 15 to the 18 of September 2012. 

You will have the unique opportunity to meet colleagues from all around the world, exchange knowledge and 

share a commonvisionforthefutureofrenalcare. 

This year’s Conference theme reflects one of the Association´s main objectives: 

st 

The 41 EDTNA/ERCA International Conference will emphasize the value of continuing education, the progress 

achieved for the best multidisciplinary clinical practice, health improvement, quality and economic impact both 

for renalcare workers and disease management. 

In addition to the multidisciplinary focused scientific programme, you will have a great opportunity to visit an 

exciting renal exhibition presenting the most up to date technology and researchinrenal care. This exhibition is 

supported by our industry partners whom we deeply thank. 

We would like to thank the Scientific Programme Committee Chair and members for their hard work to prepare a 

very interesting program, and we thank our guest speakers, editors, authors and delegates for their active 

participation. In addition we would like to thank all the volunteers, coordinators, finance team for their 

commitment, dedication and hard work to fulfil the Association’ s objectives and projects. And finally our sincere 

thanks to the Conference Department for their professional work and support throughout the year and in particular 

in the Conference 

organization. 

Strasbourg is a cosmopolitan European city with beautiful canals with an historical city Centre. The European 

Parliament is situated within walking distance of the Conference Centre. 

Welcome to the beautiful city of Strasbourg and enjoy the Alsatianculture! 

Best wishes 

EDTNA/ERCA Executive Committee 

Global Advances in Renal Care: 

Economic and Quality Impact of Disease Management 

ST 


3

CONFERENCE VENUE FLOORPLAN 

FIRST FLOOR 

INTERNAL MEETINGS 

GROUND FLOOR 

ERASME HALL 

PLENARY LECTURES, 

CES, OPENING CEREMONY 

ERASME HALL 


CES, OPENING CEREMONY 

POSTER AREA 1 

POSTER SESSIONS A, B, F, G 

4 FINAL PROGRAMME | WWW.EDTNAERCA.ORG 

TIVOLI 1 

PARALLEL SESSIONS 

EXHIBITION 

POSTER AREA 2 

POSTER SESSIONS C, D, E 

MAIN STAIRCASE 

EXHIBITIONS, SESSION HALLS 

TIVOLI 2 

PARALLEL SESSIONS 

MAIN STAIRCASE 

POSTER AREAS, REGISTRATION 

REGISTRATION 

MAIN ENTRANCE 

ERASME 

SPEAKERS’ 

PREVIEW ROOM 

SCHUMAN HALL 


CLOSING CEREMONY

COMMITTEES 

EXECUTIVE COMMITTEE (EC) 

Anastasia Laskari Immediate Past President Greece 

Alessandra Zampieron Treasurer Italy 

Maria Saraiva Secretary Portugal 

Edita Noruisiene Member Lithuania 

SUPERVISORY BOARD 

Jitka Pancířová Executive Director Czech Republic 

Elisheva Milo Secretariat Co-ordinator Israel 

Maria Cruz CasalGarcia Publication Co-ordinator Spain 

CO-OPTED EC MEMBER 

Iris Romach Israel 

CONFERENCE SCIENTIFIC PROGRAMME COMMITTEE 

Paula Ormandy Chair UK 

Helen Noble Member UK 

Anastasia Laskari EC Link Greece 

Jitka Pancířová Industry Link Czech Republic 

Ilaria De Barbieri Member Italy 

EUROPEAN DIALYSIS AND TRANSPLANT NURSES 

ASSOCIATION/EUROPEAN RENAL CARE ASSOCIATION 

(EDTNA/ERCA) 

Pilatusstrasse 35 

CH 6003 Lucerne 

Switzerland 

EDTNA/ERCA SECRETARIAT 

Eva Petrová Main Secretary 

Tomáš Nejedlý Membership Manager 

Prague Congress Centre 

5. května 65, 140 00 Prague 

Czech Republic 

EDTNA/ERCA CONFERENCE DEPARTMENT 

CZECH-IN, 5. května 65, CZ-140 21 Prague 4, Czech Republic 

Tel: +420 261 174 305, Fax: +420 261 174 307, Email: Conference2012@edtnaerca.org 

CZECH-IN has been appointed as the official organiser for this Conference. All matters regarding registration, 

accommodation, abstract handling, social events and general information are managed by CZECH-IN s.r.o. 

Conference Manager Monika Fialová 

Sponsorship and Exhibition Jana Dvořáková 

Conference Registration Anna Hrabětová 

Membership Manager Tomáš Nejedlý 

Accommodation, Volunteers, Guest Speakers Alena Foltýnová 

IT and Communication Martin Valter 

ST 


5

PROGRAMME HIGHLIGHTS 

Akeyfeature of the Conference is patient involvement and this year wehave four excellent presentations from 

specialrenalpatient guests to share their real life experiences. 

S03OPENING 

CEREMONY 

Saturday 15 September, 17:00, Erasme Hall 

Jean Louis Clemendot (France) - dialysing and free 

Pushing the edge of autonomy – pushing the edge of the world 

S07GAMBRO 

CES 

Sunday 16 September, 11: 00 - 12:30, Erasme Hall 

Darren Cawley (Ireland) 

Should renal experts consult patients when they create guidelines? 

S08PATIENT 

EMPOWERMENT 

Sunday 16 September, 11: 00 - 12:30, Tivoli 1 

Fiona Loud (UK) 

Early chronic kidney disease – self-care and patient involvement in quality improvement 

S35CLOSING 

CEREMONY 

Tuesday 18 September, 12:15 - 13:15, Schumann Hall 

Per ke Zillen (Sweden) 

From patient centred care to outcome centred partnership 

PLENARY GUEST SPEAKERS INCLUDE 

Adrian Coleman (UK) 

�Practicalpharmacokinetics 

for nurses (S01) 

Willem van Biesen (Belgium) 

�Improving 

patient outcomes: 

free choice is good for you! (S06) 

�The 

danger and how to prevent hypervolumaemia 

in PD patients (S13) 

�Overview 

of peritonitis prevention, current evidence 

base, whatcanwedotoavoid it? (S23) 

Gerhard Krönung (Germany) 

�State 

of the art AV access for haemodialysis - 

Mapping,creating, use and remodeling (S09) 

�The 

danger and how to prevent hypervolumaemia 

in PD patients (S13) 

Sara Alon (Israel) 

�Elder 

people abuse and neglect: helping renalstaff 

to detect, identify and manage (S14) 

Phil Kalra (UK) 

�The 

Importance of biomarkers in the modern 

diagnosis of AKI (S 21) 

Piergiorgio Gamba (Italy) 

�Paediatric 

kidney transplants: particular aspects (S24) 


Denis Fouque (France) 

�Epidemiology 

and diagnosis of protein energy wasting 

in kidney disease (S28) 

Ione Ashurst (UK) 

�Effectiveness 

of low-salt behavioural approach 

in the management of blood pressure (S28) 

Helen Noble (UK), Per ke Zillen (Sweden) 

�Let's 

talk about death: an interview with a patient? 

(S32) 

Danny Schneditz (Austria) 

�The 

role of bioimpedance measurements in the 

management of dialysis patients (S33) 

František Lopot (Czech Republic) 

�Evolution 

of the wearable artificial kidney - from 

concepts to reality (S33) 

Kitty Jager (Netherlands) 

�Factors 

influencing the decision to start renal 

replacement therapy: a survey among European 

nephrologists (S30) 

� Pregnancies in dialysis patients, reasons 

to start 

dialysis (S34)

S02EDTNA/ERCA 

SESSION –JOINT EDTNA/ERCA & INDUSTRY PARTNERS PROJECTS 

Saturday 15 September, 15: 15 - 16:45, Erasme Hall 

S 

Industry Projects Overview 

Jitka Pancířová (Czech Republic) 

Guidelines on Vascular Access Cannulation and Care 

Joint EDTNA/ERCA & Fresenius Medical Care project to achieve enhanced multidisciplinary renal 

team practice in HD and produce VA guidelines 

GS: Maria Teresa Parisotto (Germany) 

Next steps in joint EDTNA/ERCA & Fresenius Medical Care project "Go Green in Dialysis" 

GS: Jürgen Kastl (Germany) 

Joint EDTNA/ERCA & Shire Pharmaceuticals survey of renal nurses and dietitians 

GS: Dr Tom Pulles (Switzerland) 

IQD (Individualised Quality-assured Dialysis) 

A guide to implementing renal best practice in haemodialysis 

GS: Anki Davidson (Sweden) 

15 CELEBRATING THE WORK OF HANS-DIETRICH POLASCHEGG 

Sunday 16 September, 16:00 - 17:30, Erasme Hall 

What did Hans-Dietrich Polaschegg do for dialysis? 

GS: James Tattersall (UK) 

Introducing the principles of physiology to dialysis technology 

GS: Danny Schneditz (Austria) 

Dr. Polaschegg 

Dialysate sodium and sodium balance - an on-going task 

GS: František Lopot (Czech Republic) 

A scientific approach to safe and efficient dialysis 

GS: Elizabeth Lindley (UK) 

What really happens when you lock a catheter? Spillage and possible embolic complications 

GS: Elizabeth Lindley (UK) 

ST 


7

CORPORATE EDUCATION SESSIONS 

Erasme Hall 

All CES sessions are held in Erasme Hall and are translated from English into 3 languages (French, German 

and Spanish). In addition, the Fresenius MedicalCare sessions is also translated into Czech language. 

S04CONNECTING THE PATIENT TO LIFE: 

CENTRAL VENOUS CATHETER COMPLICATIONS CAN AND MUST BE MANAGED 

Sunday 16 September, 09:00 - 10:30 

Introduction of the session 

Cristina Miriunis (Germany) 

Think ahead: Preventing the impact of Central Venous Catheter complications 

Maurizio Gallieni (Italy) 

A life-preserving challenge: Pro-active care of the Central Venous Catheter to minimise complications 

Marjelka Trkulja (Croatia) 

Every Choice Has A Chance of Success: Your Care Counts 

Maria Teresa Parisotto (Germany) 

S07IQD 

– INDIVIDUALIZED QUALITY-ASSURED DIALYSIS 

A GUIDE TO IMPLEMENTING RENAL BEST PRACTICE IN HAEMODIALYSIS 

Sunday 16 September, 11:00 - 12:30 

Do all dialysis patients suffer from the same disease and should they receive the same prescription? 

Angela Henson (Australia) 

Will a technical algorithmic approach to guidelines be useful and acceptable to mostly non-technical 

dialysis staff? 

František Lopot (Czech Republic) 

Should renal experts consult patients when they create guidelines? 

Darren Cawley (Ireland) 

S12THINGS 

YOU ALWAYS WANTED TO KNOW ABOUT DIALYSIS 

BUT WERE AFRAID TO ASK 

Sunday 16 September 2012, 14:00 - 15:30 

How do I dialyse a patient while they are waiting for a transplant? How to clinically connect what you 

do today (dialysis) with the patients future option (transplant) 

Claire Main (United Kingdom) 

How do I manage diabetics patients on PD? A review of techniques and tools to manage this very 

common group of patients without adding to their glucose load 

Carlos Cruz (Portugal) 

How do I stop haemodialysis patients dying on a Monday morning? A review of High Dose HD and how it 

can help to avoid sudden deaths that may occur with conventional HD after a weekend without dialysis 

Markku Asola (Finland) 

How do I set-up a Home HD programme? What you need to think of and do when setting up a Home 

HD programme. Some very practical tips 

Frankie O'Kane (N. Ireland / UK) 

How should I support patients to make the right treatment decision? Structured Treatment Option 

Education and the use of decision aids to support patients to make the right decision with an 

emphasis on the principle that “Information alone” is not enough 

Eva-Lena Nilsson (Sweden) 


S19 

Monday 17 September 2012, 09:00 - 10:30 

S22 

Monday 17 September 2012, 11:00 - 12:30 

S27 

BALANCING PHOSPHATE AND PROTEIN INTAKE IN PATIENTS WITH CKD 

Chair's Welcome 

Denis Fouque (France) 

Protein intake and phosphate control in patients undergoing dialysis 

Elaine Corden (United Kingdom) 

Enabling adequate protein intake: the critical role of phosphate binders 

Peters Harm (Germany) 

The challenge of non-adherence 

Rob Horne (United Kingdom) 

THE FUTURE OF DRUG MANAGEMENT IN HAEMODIALYSIS 

Typical drug therapies for patients on haemodialysis 

Christoph C. Haufe (Germany) 

Challenges for today's drug management procedures in daily routine 

Cathy Johnson (United Kingdom) 

Changing for the better – needle free i.v. drug application in the future 

Marta Arias (Spain) 

PAIN, ANXIETY, BLEEDING, BUMPS AND LUMPS! 

IMPROVING THE PATIENTS AV FISTULA EXPERIENCE 

Monday 17 September 2012, 1 4:00 - 1 5:30 

Pain, anxiety, bleeding, bumps and lumps! – Improving the patients AV fistula experience 

Janet Cowperthwaite (United Kingdom) 

Patients’ perception of pain and anxiety during AV fistula cannulation 

Filiz Akdeniz (Turkey) 

The gold standard lifeline – but how do AV fistula affect patients Quality of Life 

Caroline Herlin (Sweden) 

Improving the patients AV fistula experience? 

Nora Zajko (Hungary) 

Listen to what the patients say 

Mari Paz Sorribes (Spain) 

ST 


9

WORKSHOPS 

S05 

LEADING EFFECTIVE CHANGE IN CLINICAL PRACTICE 

Sunday 16 September, 09:00 - 10:30, Tivoli 1 

Limited capacity on a basis „first come first serve“ (40 pax) . Please register for the workshop at the Registration desk onsite: 

Saturday 15 September (10:30-20:00) & Sunday 16 September (7:30-8:30). 

S 10 PHARMACOLOGY WORKSHOP 

Sunday 16 September, 12:45 - 13:45, Tivoli 1 

S13COMPLEX 

CASE MANAGEMENT 

THE DANGER AND HOW TO PREVENT HYPERVOLUMAEMIA IN PD PATIENTS & REMODELING OF VASCULAR ACCESS 

Sunday16September,14: 00-1 5 :30, Tivoli1 

S 16 ELDER ABUSE AND NEGLECT –IDENTIFICATION AND INTERVENTIONS 


Please register for the workshop at the Registration desk onsite: Saturday 15 September (10:30-20:00) & Sunday 16 September (7:30-14:00). 

S20HOW 

TO HELP PATIENTS TO HELP THEMSELVES 

Monday17September,0900-10:30 : , Tivoli1 

S25GREEK 

WORKSHOP –ACUTE RENAL FAILURE 

Monday17September,1245-13:45 : , Tivoli1 

LUNCH SATELLITE SYMPOSIA 

S 11 LEADING EFFECTIVE CHANGE IN CLINICAL PRACTICE 


S 26 DOPPS SYMPOSIUM 

HAEMODIALYSIS PRACTICES:NEW TRENDS AND ASSOCIATIONS 

WITH OUTCOMES IN THE INTERNATIONAL DIALYSIS OUTCOMES 

AND PRACTICE PATTERNS STUDY (DOPPS) 

Monday 17 September, 12: 45 - 13:45, Tivoli 2 

ONE MINUTE MADNESS 

WITHIN SESSION 

S 31 SHORT ORAL PRESENTATIONS 

Monday 17 September, Tivoli 1, 16:00-17:30 

What'sonyourmind?OneMinuteMadness is YOUR chance as a delegate to share your research evidence with 

fellow delegates, demonstrate the impact you've made, discuss the value of a current or proposed research 

project, or simply have your say about Nephrology care. One minute is all it takes, and your project could be the 

talk of the Conference! 

There are 10 one minute slots available. 

Interested? Sign up NOW at the Registration desk. 


S 18 

ANNUAL GENERAL MEETING 

Sunday 16 September, 17:45 - 19:15, Erasme Hall 

1. Welcome by the Immediate Past President 

2. Association activities & progress report 

3. Approval of 2011 Financial report 

4. EC election results 

5. Volunteers acknowledgement 

6. Motions 

7. Life time member 

S 35 CLOSING SESSION 

Tuesday 18 September, 12:15 - 13:15, SchumanHall 

From patient centred care to outcome centred partnership 

GS: Per ke Zillen (Sweden) 

Presentation of Best Poster - Scholarships awards 

COUNTRY MEETINGS 

Participants of the same country are given the opportunity to meet and discuss relevant issues concerning 

the Conference and Association. These sessions are organised and chaired by KEY MEMBER. 

Spain 

Greece 

Sunday 16 September 16:00 - 17:30, Leicester 2 

Monday 17 September 12:45 - 13:45, Tivoli 1 

RESTRICTION OF TAKING PICTURES 

8. EDTNA/ERCA Manuscript and Scholarship award 

9. EDTNA/ERCA Accreditation & Endorsement 

of Education programmes 

10. Future Conference 

11. Any other business 

12. Date and venue for next AGM 

13. Close of the meeting 

All participants are kindly asked not to take pictures of the presentations during sessions 

st 

at the 41 EDTNA/ERCA International Conference as it might disturb the speaker itself as 

well astheaudience during the session. 

SCIENTIFIC PRESENTATIONS 

The scientific presentations will be available for the EDTNA/ERCA members after the Conference on the 

EDTNA/ERCA website (www.edtnaerca.org). 

ELECTRONIC ABSTRACT BOOK 

The Abstract Book will be distributed on USB in electronic version only. 

Each delegate will receive and Abstract Book voucher to pick up atGambro stand no.7 in the Exhibition area. 

ST 


11

POSTER SESSIONS 

Posters will be displayed continuously throughout the whole Conference, 15-18 September 2012. 

Location: Ground Floor, Pins/Velcro for mounting posters is available at the Poster desk located in the poster area. 

Poster Mounting 

Saturday 15 September (12:00 - 17:00) 

All posters not removed at the end of the Conference will be discarded. 

MODERATED POSTER SESSIONS 

All authors are requested to be present next to their poster during their allocated moderated poster session. 

POSTER SESSION A Monday 17 September 09:00 - 10:30 

Peritoneal Dialysis P 001 - P 018, P 132 

POSTER SESSION B 

Transplantation 

CKD Prevention and Delay 

Paediatric Care 

Open Forum 

Monday 17 September 09:00 - 10:30 

P 019 – P 025, P 135 

P 026 – P 030 

P 031 - P 032 

P 033 

POSTER SESSION C Monday 17 September 11:00 - 12:30 

Open Forum P 034 – P 052 

POSTER SESSION D Monday 17 September 11:00 - 12:30 

Haemodialysis 

Vascular Access 

P 053 - P 054 

P 055 – P 074 

POSTER SESSION E Monday 17 September 11:00 - 12:30 

Haemodialysis P 075 – P 096, P 133 

POSTER SESSION F Monday 17 September 14:00 - 15:30 

Education of staff/patients P 098 – P 114, P 134 

POSTER SESSION G Monday 17 September 14:00 - 15:30 

Service Management, Quality and Audit 

Psychosocialcare 

Open Forum 

Haemodialysis 

Poster Removal 

Tuesday 18 September 2012 (11:45 - 14:00) 

P 116 – P 122 

P 123 – P 129 

P 130 

P 131 

Selected authors ( P 052, P 073, P 094, P 095, P 096, P 113, P 114) 

will also be presenting their poster in the Short 

OralsessionS31onMonday, 17 September, 16:00 Tivoli 1. 

All posters are eligible for the Poster Scholarship, but must be displayed until Tuesday 18 September 2012, 11:45. 

Presentation of Best Poster -Scholarships award will be presented at the Closing Ceremony, 18 September, 

SchumanHall 12:15 


POSTER AREA FLOORPLAN 

Poster area is split based on Poster Sessions assignment - see the detail below. 

POSTER AREAS 

GROUND FLOOR 

P 001 

- 

P 008 

P 009 

- 

P 016 

ERASME 

HALL 

P 017 

- 

P 024 

P 025 

- 

P 032 

POSTER AREA 2 

P 075 - P 135 

REGISTRATION AREA 

MAIN ENTRANCE 

CLOAKROOM 

POSTER AREA 1 

P 001 - P 074 

POSTER AREA 1 POSTER AREA 2 

P 033 

- 

P 040 

P 041 

- 

P 048 

P049 

- 

P056 

P 057 

- 

P 064 

P065 

- 

P069 

P 070 

- 

P 074 

P091 

- 

P099 

P083 

- 

P090 

P 122 

- 

P 129 

P 113 

- 

P 121 

P 100 

- 

P 107 

P 075 

- 

P 082 

P 130 

- 

P 135 

P 108 

- 

P 112 

ST 


13

EDTNA/ERCA MANUSCRIPT SCHOLARSHIP 

W INNER – 500 EUR - BEST MANUSCRIPT SCHOLARSHIP 

O03 

Effects on the caregiver burden of the home-based educational programme for dialysis patients 

1 2 

Mukadder Mollaoglu , M. Kayatas 

1 

Cumhuriyet University, Nursing, Sivas, Turkey 

2 

Cumhuriyet University, Nephrology, Sivas, Turkey 

CERTIFICATE OF MERIT 

P 024 

Being overweight negatively affects graft function in patients receiving a transplant from a deceased donor 

1 2 3 2 4, 2 3 

ΚαΙΙiορi-Αηηα Poulia ,L.Tsirigoti,M.Darema,V.Iatridi,G.ZavosM.Kontogianni,J.Boletis 1 

Laiko Hospital Athens Greece, Department of Nutrition & Dietetics, Athens, Greece 

2 

Harokopio University of Athens, Department of Nutrition & Dietetics, Athens, Greece 

3 

Laiko Hospital Athens Greece, Department of Nephrology & Transplantation Center, Athens, Greece 

4 

Laiko Hospital Athens Greece, Transplantation Unit, Athens, Greece 

O04 

Health professionals’ perceptions on the JPAT- a screening tool for home haemodialysis suitability 

1 

Josephine Chow 

1 

South Western Sydney Local Health District, Clinical & Business Service, Sydney, Australia 

The Manuscript Scholarship will be presented during the EDTNA/ERCA Annual General Meeting 

Sunday, 16 September, 17:45-19:15, Erasme Hall. 


ST 


15

SCIENTIFIC PROGRAMME 

SATURDAY 15 SEPTEMBER 2012 


SUNDAY 16 SEPTEMBER 

ST 


17

SUNDAY 16 SEPTEMBER 


MONDAY 17 SEPTEMBER 

ST 


19

MONDAY 17 SEPTEMBER 


TUESDAY 18 SEPTEMBER 

DISCLAIMER: 

The organiser reserves the right to alter the programme if and as is deemed necessary. 

The EDTNA/ERCA and/or its agents have the right for any reason beyond their control to alter or cancel, without 

prior notice, the Conference or any of the arrangements, time tables, plans or other items relative directly or 

st 

indirectly to the 41 EDTNA/ERCA International Conference. The EDTNA/ERCA and/or its agents shall not be liable 

for any loss, damage, expenditure or inconvenience caused as a reset of such alteration or cancellation. 

ST 


21

LIST OF POSTERS 

POSTER SESSION A Monday 17 September 09:00 - 10:30 

Peritoneal Dialysis P 001 - P 018, P 132 

P 001 

CAPD patients are more volume expanded than are haemodialysis patients 

1 

Y. Lutfiye 

1 

Eskisehir Osmangazi University Faculty of Medicine, Hospital nefroloji dializ, Eskisehir, Turkey 

P 002 

Evaluation of efficacy of exercise in quality of life in PD 

1 

Y. Lutfiye 

1 

Eskisehir Osmangazi University Faculty of Medicine, Hospital nefroloji dializ, Eskisehir, Afghanistan 

P 003 

Treatment and prevention of peritoneal dialysis-related peritonitis 

1 1 1 1 1 

D. Urdarevik ,S.Isakovska,P. Krstevska , S. Stojanovska , C. Popovska 

1 

University Clinic of Nephrology, Peritoneal dialysis, Skopje, Macedonia 

P 004 

More than 11 years on peritoneal dialysis - case report 

1 1 

C. Popovska , S. Isakovska 

1 

University Clinic of Nephrology, Peritoneal dialysis, Skopje, Macedonia 

P 005 

Nursing experiences with patients transferred from haemodialysis to peritoneal dialysis in Hungarian B.Braun 

Network 

1 1 1 1 2 

M. Király , K. Tölgyesi , E. Macsai , A.Benke,L.Gergely 

1 

B.Braun Avitum, 3rd Dialysiscenter, Veszprem, Hungary 

2 

B.Braun Avitum, Headquarters, Budapest, Hungary 

P 006 

Early detection of peripheral vascular disease as a patient educational proposal in peritoneal dialysis 

1 1 1 

K. Tölgyesi ,E.Macsai,A.Benke 

1 

B.Braun Avitum, 3rd Dialysisscenter, Veszprem, Hungary 

P 007 

Treating nasal Staphylococcus aureus carriers in the prevention of exit site/tunnel infection and peritonitis 

1 1 1 1 2 3 

B. Ponikvar Savicki ,B.Karas,N.Pavlic,A.Gucek,V.HergouthKrizan,T.Pintar 

1 

University clinical centre, Department of Nephrology, Ljubljana, Slovenia 

2 

University of Ljubljana, Institute of Microbiology and Immunology, Ljubljana, Slovenia 

3 

University clinical centre, Department of abdominal surgery, Ljubljana, Slovenia 

P 008 

An extraordinary paediatric peritoneal dialysis patient 

1 1 

T. Sanli , N. Bozkurt 

1 

Akdeniz University Faculty of Medicine, Nephrology-Peritoneal Dialysis Unit, Antalya, Turkey 

P 009 

The effect of a reduced dialysis dose on residual renal function 

1 1 

B. Bátor ,K.Schneider 

1 

B.Braun Avitum Hungary, Dialysis Centre No. 11, Gyor, Hungary 

P 010 

FDG-PET in peritoneal dialysis: the current and future prospects 

1 1 1 1 

M. Fiorito , M.P. Zito , C. Raimondi , I. Capelli 

1 

Nefrologia Dialisi e Trapianto Stefoni, Medicina Interna dell'Invecchiamento e Malattie nefrologiche, Bologna, Italy 


P 011 

The importance of patient education and training in reducing peritonitis rates 

1 1 1 1 

S. McEntee , N. Oakley , K. Simms , J. Postlethwaite 

1 

University Hospital Birmingham, CAPD Unit, Birmingham, United Kingdom 

P 012 

Development and implementation of a robust assessment tool to improve outcomes for peritoneal dialysis 

patients 

1 2 2 2 2 3 

J. Woodhouse , C. Lewis , P. Lewis , K. Marks , E. Sharples , T. Ansell 

1 

Oxford University Hospitals NHS Trust, Renal Unit, Oxford, United Kingdom 

2 

Oxford University hospitals NHS Trust, Renal Unit, Oxford, United Kingdom 

3 

Baxter Healthcare LTD, Renal, Newbury, United Kingdom 

P 013 

'Forced PD' because of inadequate blood access (case study) 

1 1 1 

A. Szigeti ,P. Fábián , C. Nagy 

1 

B.BRAUN Avitum Hungary, 8. Dialysis Centre, Tatabánya, Hungary 

P 014 

The effect of qualification and social situation on recurrence of peritonitis among PD patients 

1 1 

G. Barna , I. Menes 

1 

B.Braun Avitum Hungary, 10. Dialysis centre, Debrecen, Hungary 

P 015 

Peritoneal equilibrium test satisfaction scale validity and reliability: preliminary study 

1 2 3 

E. Topbas ,G.Can,R.Ataman 

1 

Amasya University School of Health, Nursing, Amasya, Turkey 

2 

Istanbul University Nursing Faculty, Nursing, Istanbul, Turkey 

3 

Istanbul University Cerrahpasa Medical Faculty, Nephrology, Istanbul, Turkey 

P 016 

Should PD treatment be practiced by the patient or their relative? 

1 1 1 1 2 2 

C. Turkmen , D. Balci , D. Efeyurtlu , A. Kilci , E. Celik , A. Demirbas 

1 

Antalya Education and Research Hospital, Peritoneal Dialysis Unit, Antalya, Turkey 

2 

Eczacibasi Baxter, Renal Product, Antalya, Turkey 

P 017 

Peritoneal dialysis catheter obstruction by a fallopian tube: a case report 

1 1 

N. Bednjanec ,L.Peter 

1 

University Hospital Merkur, Department of Medicine, Zagreb, Croatia 

P 018 

Social functionality in peritoneal dialysis and haemodialysis patients 

1 2 3 2 4 2 1 1 

T. Aksoy ,R.Kasap,S.Sepitci,N.Eren,N.Bulut,T.Emre,S.Trabulus,R.Ataman 

1 

I.U.Cerrahpasa faculty of Medicine Internal diseases department peritoneal dialysis unit, Nephrology, Istanbul, Turkey 

2 

Istanbul training and research hospital, Nephrology, Istanbul, Turkey 

3 

Cerrahpasa faculty of Medicine Internal diseases department peritoneal dialysis unit, Nephrology, Istanbul, Turkey 

4 

I.U. the department of biostatiscs and medical informatics, Biostatistics, Istanbul, Turkey 

P 132 

Hydration status and factors associated with water balance disturbance in peritoneal dialysis patients 

1 1 2 1 

J. Sorokina , T. Glushenkova , M.T. Parisotto , L. Grinkova 

1 

Fresenius Medical Care, Fresenius NephroCare, Ulyanovsk, Russia 

2 

Fresenius Medical Care, NephroCare Coordination, Bad Homburg, Germany 

ST 


23

POSTER SESSION B Monday 17 September 09:00 - 10:30 

Transplantation 

P 019 – P 025, P 135 

CKD Prevention and Delay 

P 026 – P 030 

Paediatric Care 

P 031 - P 032 

Open Forum 

P 033 

P 019 

Significance of education in increasing live - donor transplantation rate 

1 1 1 

M. Majerné Szabó ,G.Varga,A. Borisz 

1 

B.Braun dialysis center, B.Braun dialysis center, Ajka, Hungary 

P 020 

Renal transplantation in elderly patients: risks and benefits 

1 1 1 1 

M. Kljak , M. Maretic Dumic , R. Balic , N. Basic Jukic 

1 

Department of Internal Medicine, Department of Nephrology Hypertension and Dialysis, Zagreb, Croatia 

P 021 

Care methodology in the emotional manifestations of renal transplant patients subject to a biopsy 

1 1 1 

M. Pérez Doctor , T. López Sánchez , M. Amoedo Cabrera 

1 

Virgen del Rocio Hospital, Renal transplantation, Sevilla, Spain 

P 022 

ABO incompatible living donor transplantation- the first experience in Skopje 

1 2 2 3 

V. Tancevska ,K.Velkovska,G.Severova-Andreevska , D. Eftimova 

1 

University Clinic of Nephrology, Renal transplant unit, Skopje, Macedonia 

2 

University Clinic of Nephrology, Intensive care unit, Skopje, Macedonia 

3 

University Clinic of Urology, Transplant Centre, Skopje, Macedonia 

P 023 

Psycho-social issues in kidney donors: literature review 

1 2 3 

I. de Barbieri , M. Baccega , A. Zampieron 

1 

Padua University Hospital, Pediatric Department, Padua, Italy 

2 

past student Padua University, School of Nursing, Padua, Italy 

3 

Padua University Hospital, School of Nursing, Padua, Italy 

P 024 

Being overweight negatively affects graft function in patients receiving a transplant from a deceased donor 

1 2 3 2 4 2 3 

K. Poulia , L. Tsirigoti , M. Darema , V. Iatridi , G. Zavos , M. Kontogianni , J. Boletis 

1 

Laiko Hospital Athens Greece, Department of Nutrition & Dietetics, Athens, Greece 

2 

Harokopio University of Athens, Department of Nutrition & Dietetics, Athens, Greece 

3 

Laiko Hospital Athens Greece, Department of Nephrology & Transplantation Centre, Athens, Greece 

4 

Laiko Hospital Athens Greece, Transplantation Unit, Athens, Greece 

P 025 

Development of a health education prospectus for renal transplant patients with diabetes mellitus 

1 1 1 

T. López Sánchez , M. Pérez Doctor , M. Amoedo Cabrera 

1 

Virgen del Rocio Hospital, Renal transplantation, Sevilla, Spain 

P 026 

Evaluation of familial history in patients with chronic kidney disease 

1 1 1 1 1 

O. Duzgun ,D.Aydin , Y. Caliskan , N. Aysuna , M.S. Sever 

1 

Istanbul Medical Faculty Istanbul University, Nephrology Dialysis Unit, Istanbul, Turkey 


P 027 

Chronic kidney disease: changing the focus from treatment to prevention 

1 

R. Elliott 

1 

University of Southern Mississippi, School of Nursing, Hattiesburg, USA 

P 028 

Health screening for risk factors of chronic kidney disease in Owerri 

1 

G. Orunmuyiwa 

1 

Federal Medical Centre Owerri, Nursing Service Department, Owerri, Nigeria 

P 029 

Knowledge of chronic kidney disease and practice of preventive measures among people in Owerri 

1 

G. Orunmuyiwa 

1 

Federal Medical Centre Owerri, Nursing Service Department, Owerri, Nigeria 

P 030 

eGlomerular Filtration Rate is not associated with uraemic toxin concentrations 

1 1 1 2 2 2 1 1 2 

S. Eloot , S. Claus , E. Schepers , D. Barreto , F. Barreto , S. Liaboeuf , W. Van Biesen , G. Glorieux , Z. Massy , R. 

1 

Vanholder 

1 

Ghent University Hospital, Nephrology, Ghent, Belgium 

2 

Amiens University Hospital, Clinical Research Centre, Amiens, France 

P 031 

Peritoneal dialysis and pets: analysis of paediatric clinical cases 

1 2 3 

I. de Barbieri ,I.DePasco,A. Zampieron 

1 

Padua University Hospital, Pediatric Department, Padua, Italy 

2 


3 


P 032 

Care for an adolescent with ESRD, AIDS, Kawasaki syndrome: analysis of a clinical case 

1 2 3 

I. de Barbieri ,R.Vomiero,A. Zampieron 

1 

Padua University Hospital, Pediatric Department, Padova, Italy 

2 


3 


P 033 

What information-related activities do people with ESKD use? 

1 2 3 

A. Bonner , A.Lloyd,C.Dawson-Rose 

1 

Queensland University of Technology, School of Nursing, Brisbane, Australia 

2 

Charles Sturt University, School of Information Studies, Wagga Wagga, Australia 

3 

University of California, Faculty of Nursing, San Francisco, USA 

P 135 

Transplantation and organ donation: the role of health professionals 

1 

P. Palla 

1 

GeneralHospitalOfAthens "G.Gennimatas", dialysis unit, Athens, Greece 

ST 


25

POSTER SESSION C Monday 17 September 11:00 - 12:30 

Open Forum P 034 – P 052 

P 034 

Psychological discomfort (PD), Quality of life (QoL) and Cytokine profile in haemodialysis patients (HDP) 

1 1 

G.P. Iaffaldano ,V.Montinaro 

1 

Nephrology, Nephrology Dialysis and Transplantation, Bari, Italy 

P 035 

Knowledge of coping with emergency situations in patients on haemodialyis 

1 1 1 1 

K. Szautner , K. Tölgyesi , E. Macsai , A.Benke 

1 rd 

B.Braun Avitum, 3 Dialysiscenter, Veszprem, Hungary 

P 036 

Importance of surveillance of nails in haemodialysed patients 

1 1 1 1 

M. Csoma , K. Tölgyesi , E. Macsai , A.Benke 

1 rd 


P 037 

On-line predilution versus postdilution haemodiafiltration: a comparative study of dialysis efficiency and 

haemodynamic stability 

1 1 1 1 1 

R. Menezo Viadero , M. Garcia Martinez , R. Pelayo Alonso , J.L. Cobo Sánchez , M. Rojo Tordable , A. Tovar 

1 1 1 1 1 

Rincón , V. Olalla Antolin , A. Saenz de Buruaga Perea , H. Cepa Garcia , E. Incera Setién 

1 

Hospital Marques de Valdecilla, Nephrology, Santander, Spain 

P 038 

Salt consumption, quality of life and compliance to diet in chronic haemodialysis patients 

1 2 1 2 

B. Oren ,O.Duzgun,N.Zengin,A.Yildiz 

1 

Faculty of Health Sciences Istanbul University, Department of Internal Medicine, Istanbul, Turkey 

2 

Istanbul Medical Faculty Istanbul University, Division of Nephrology, Istanbul, Turkey 

P 039 

Acceptability of a granule formulation of the new phosphate binder Colestilan in healthy subjects 

1 2 2 3 3 

F. Senatore , S. Nakajima , K. Takei , H. Egawa , A. Manning 

1 

Mitsubishi Tanabe Pharma Development America Inc, Clinical, New Jersey, USA 

2 

Mitsubishi Tanabe Pharmaceutical Corporation, Clinical, Tokyo, Japan 

3 

Mitsubishi Pharma Europe Ltd, Clinical, London, United Kingdom 

P 040 

Individualisation of dialysate sodium concentration and fluid balance in HD patients 

1 1 1 1 

L. Vackova ,M.Sejkorova,P. Vagenknechtova , F. Lopot 

1 

General University Hospital, Department of Medicine Strahov, Prague 6, Czech Republic 

P 041 

Benefits of an endurance training programme in patients on haemodialysis: time for action 

1 1 1 1 1 

A.Junque,L.Moreno,V.Esteve,M.Lavado,M.RamírezdeArellano 

1 

Consorci Sanitari De Terrassa, Nephrology, Terrassa, Spain 

P 042 

"Shared Care", home haemodialysis and the expert patient 

1 

S. Appleby 

1 

Hull & East Yorkshire Trust, Haemodialysis Unit, Hull, United Kingdom 

P 043 

Analysis of serum phosphate control in patients new to haemodialysis 

1 2 2 3 1 4 

K. Farrand , J.B. Copley , J. Heise , M. Fridman , M. Keith , A. Silverberg 

1 

Shire Pharmaceuticals, Global Health Economics Outcomes Research and Pharmacoepidemiology, Wayne PA,USA 

2 

Shire Pharmaceuticals, Clinical Development and Medical Affairs, Wayne PA,USA 

3 

AMF Consulting, Statistics, Los Angeles CA,USA 

4 

Shire Pharmaceuticals, Clinical Development Operations and Biostatistics, Wayne PA,USA 


P 044 

Relationship between communication skills and depression levels in nurses working in haemodialysis units 

1 1 2 1 1 1 

D. Aydin ,O.Duzgun,B.Oren,M.Yavuz,N.Aysuna , A.Yildiz 

1 

Istanbul Medical Faculty Istanbul University, Nephrology Dialysis Unit, Istanbul, Turkey 

2 

Faculty of Health Sciences Istanbul University, Department of Internal Medicine, Istanbul, Turkey 

P 045 

The impact of the dietician's intervention upon achieving quality patient dialysis outcomes in Saudi Arabia 

1 2 3 

A. Bunani , J. Sedgewick , A. Al Lehbi 

1 

Davita. Lehbi Care, Clinical Services, Riyadh, Saudi Arabia 

2 

Teesside University, School of Health and Social Care, Cleveland, United Kingdom 

3 

Davita.Lehbi Care, Medicine, Riyadh, Saudi Arabia 

P 046 

Importance of monitoring blood volume in patients with intradialytic hypertension 

1 2 3 

Y. Kazankova ,T.Glushenkova,M.T.Parisotto 

1 

Fresenius Medical Care, Fresenius NephroCare Dialysis Center, Saransk, Russia 

2 

Fresenius Medical Care, Fresenius NephroCare Dialysis Center, Ulyanovsk, Russia 

3 


P 047 

Assessment of glycosylated haemoglobin in haemodialysis patients 

1 2 3 

A.Varga, 

S. Kiss , R. Mogyorosi 

1 

Fresenius Medical Care, FMC NC Miskolc, Miskolc, Hungary 

2 

Fresenius Medical Care, Nursing Care, Miskolc, Hungary 

3 

Fresenius Medical Care, Dialysis Centre Ltd., Budapest, Hungary 

P 048 

Clotting during extracorporeal dialysis procedures: what are the causes? 

1 1 1 1 1 1 2 3 

M. Agostinho ,C.Albuquerque , N. Gomes , A.F. Martins , C. Miranda , A. Seabra , J. Fazendeiro , M.T. Parisotto 

1 

Fresenius Medical Care, NephroCare Coimbra, Coimbra, Portugal 

2 

Fresenius Medical Care, Director Nursing Care, Lisbon, Portugal 

3 


P 049 

The relation of nutritional parameters with treatment factors 

1 1 1 1 1 2 3 

A.R. Lino , A.P.Bernardo,C.Pissarra,H.Araújo,J.Godinho,J.Fazendeiro,M.T.Parisotto 

1 

Fresenius Medical Care, NephroCare Covilha, Covilha, Portugal 

2 


3 


P 050 

The relation of nutritional parameters with socioeconomic and demographic factors 

1 1 1 1 1 2 3 

A.R. Lino , A.P.Bernardo,C.Pissarra,H.Araújo,J.Godinho,J.Fazendeiro,M.T.Parisotto 

1 

Fresenius Medical Care, NephroCare Covilha, Covilha, Portugal 

2 


3 


P 051 

Effects of non-compliance to medication with phosphate binders 

1 1 2 3 

A.C. Marquito ,F. Gomes , J. Fazendeiro , M.T. Parisotto 

1 

Fresenius Medical Care, Nephrocare de Vila Franca de Xira, Vila Franca de Xira, Portugal 

2 


3 


P 052/O 42 

Making home haemodialysis a feasible treatment option for renal patients 

1 

L. Hignell 

1 

Portsmouth Hospital Trust, renal, Portsmouth, United Kingdom 

ST 


27

POSTER SESSION D Monday 17 September 11:00 - 12:30 

Haemodialysis 

Vascular Access 

P 053 

Comparison of venous needle dislodgement score and Charlson comorbidity index in elderly haemodialysed patients 

1 1 1 1 

R. Némethné Völgyi , K. Tölgyesi , E. Macsai , A. Benke 

1 rd 


P 054 

Vascular access in chronic haemodialysis patients: over 2,309 vascular access 

1 1 1 1 

N. Ghazouani ,M.A. Frih , M.L. Skhiri , M. El May 

1 

University hospital, Hemodialyse, Monastir, Tunisia 

P 055 

Influence of vascular access modality on the quality of life of haemodialysis patients 

1 1 1 1 1 

J.L. Cobo Sánchez ,R.PelayoAlonso , M. Reyero López , A. Saenz de Buruaga Perea , A. Tovar Rincón , R. Alonso 

1 1 1 1 1 

Nates , A. Begines Ramirez , M.T. Sola García , A. Cano Gil , M.E. Incera Setién 

1 

Hospital Marques de Valdecilla, Servicio de Nefrología, Santander, Spain 

P 056 

Catheter-related bloodstream infections incidence in haemodialysis patients: luer-lock cap use versus direct connection 

1 1 1 1 1 

J.L. Cobo Sánchez ,R.PelayoAlonso , R.A. Sainz Alonso , M.Y. Vicente Jiménez , H. Cepa García , R. Menezo 

1 1 1 1 1 

Viadero , E. Ibarguren Rodríguez , A.I.PérezGarmilla,M.RojoTordable,R.Alonso Nates 

1 


P 057 

Efficacy of chlorexidine-impregnated sponge in the treatment of exit-site haemodialysis catheter with 

infection signs 

1 1 1 1 1 

J.L. Cobo Sánchez ,R.PelayoAlonso , M.E. Incera Setién , A. Saenz de Buruaga Perea , H. Cepa García , E. 

1 1 1 1 1 

Ibarguren Rodríguez , M.Y. Vicente Jiménez , R.A. Sainz Alonso , S. Peiró Sampayo , R. Alonso Nates 

1 


P 058 

Steal Syndrome: the roll of nursing intervention in preventing complications 

1 1 1 1 

Y. Peleg ,E.Badaev,N.Elshtein,V.Shani 

1 

Haim Sheba medical center, nephrology, Ramat-Gan, Israel 

P 059 

Repair of tunnelled haemodialysis catheters with silicone moulds. Experience in our unit 

1 1 1 1 1 

M. Brazalez Tejerina , L. Melero Salas , A. Alarcia Martin , C. Franco Valdivieso , M.J.RollandelaSota 

1 

Hospital Clinico Universitario de Valladolid, Nephrology, Valladolid, Spain 

P 060 

Urokinase for treatment of thrombosis-related dysfunction of tunnelled haemodialysis catheters 

1 1 1 1 1 

N. Van Paesschen ,M.Roden,S.Goossens,C.Tielemans,K.M.Wissing 

1 

VUB UZ Brussels, Haemodialysis, Brussels, Belgium 

P 061 

Clinical evaluation of a silver -pad dressing on long-term CVC exit-site 

1 

M. Canzi 

1 

Hospital S.Maria degli Angeli, Hemodialysis, Pordenone, Italy 

P 062 

Catheter-related Pseudomonas aeruginosa infection 

1 1 1 

C. Egri ,G.Csonka,T.Szelestei 

1 th 

B.Braun Avitum Hungary, 4 Dialysis Center, Kaposvár, Hungary 

P 063 

Dialysis access determines quality of life 

1 1 1 2 2 3 

K. Hudi , G. Ronas , M. Tapolyai , Z. Lengvarszki , T. Szarvas , J. Nemeth 

1 

B.Braun Avitum Zrt., Dializiskozpont, Dunaujvaros, Hungary 

2 

Louisiana State University, Department of Mathematics, Shreveport, USA 

3 

B.Braun Avitum Zrt, Dializiskozpont, Dunaujvaros, Hungary 


P 053 - P 054 

P 055 – P 074

P 064 

Ultrasound guided cannulation versus typical cannulation in haemodialysis patients 

1 1 1 2 3 

L. Theodosopoulos , A. Mpokari , E. Sarris , A. Karagkouni , D. Topka 

1 

West Attica Hospital, Hemodialysis Unit, Athens, Greece 

2 

West Attica Hospital, Nursing Administration, Athens, Greece 

3 

"Hippokratio" Athens Hospital, Nursing Administration, Athens, Greece 

P 065 

The importance of early recognition of fistula complications for effective dialysis - the nurse's role 

1 

I. Moga 

1 

B.Braun Avitum Hungary, 8. Dialysis Centre, Tatabánya, Hungary 

P 066 

Buttonhole technique in practice – comparison of patient outcomes with previous techniques 

1 1 1 

B. Carew ,L.Chackoo,J.Jacob 

1 

Tullamore Hospital, Renal Dialysis, Tullamore, Ireland 

P 067 

Vascular access recirculation measured by low blood flow method: predictive factors and haemodialysis 

efficiency 1 1 1 1 2 1 1 

D. Papadaki ,N.Mantoulidis,S.Psoma,A. Pitsidimou , K. Panagiotopoulos , V. Filiopoulos , D. Vlassopoulos 

1 

Amalia Fleming General Hospital, Nephrology, Athens, Greece 

2 

Amalia Fleming General Hospital, Biochemistry, Athens, Greece 

P 068 

The role of the medical nurse in patients with pre-dialysis arteriovenous fistula creation 

1 1 1 1 1 1 1 1 

M. Danceva ,S.Ljoki,V.Gerasimovska,L.Gruevska,D.Postolova,B.Kalkus,C.Popovska,S.Pejkovska,P. 

1 1 

Dejanov , A.Oncevski 

1 

University Clinic of nephrology, Vascular access unit, Skopje, Macedonia 

P 069 

Nurses, catheters and infection risk: a new way to manage 

1 1 1 1 1 

R. Beltrandi ,C.Elia,A.Iacobelli,E.Trastullo,V.Guadagno 

1 

Ospedale Malpighi, Nephrology Dialysis and Hipertension Department, Bologna, Italy 

P 070 

Introduction of Tri-sodium Citrate 46.7 % as a locking solution for haemodialysis catheters 

1 2 2 1 3 1 4 

G. McCrory , A. Stack , A.Mutwali,A. Mulhern , M. Mulhern , H. Nursing Team , C. Infection Control 

1 

Letterkenny General Hospital, Haemodialysis, Letterkenny, Ireland 

2 

Letterkenny General Hospital, Nephrology, Letterkenny, Ireland 

3 

Letterkenny General Hospital, Microbiology, Letterkenny, Ireland 

4 

Letterkenny General Hospital, IPC, Letterkenny, Ireland 

P 071 

Pain and dialysis efficiency - comparing needles of different gauges 

1 2 2 2 3 

B. Costa Pinto , T. Galhofas , C. Gon?alves , F. Gomes , J. Fazendeiro 

1 

Fresenius Medical Care, NephroCare, Lisbon, Portugal 

2 

Fresenius Medical Care, NephroCare Vila Franca de Xira, Vila Franca de Xira, Portugal 

3 


P 072 

Proactive role of nursing in arteriovenous graft monitoring - early detection of stenosis 

1 1 2 3 

R. Sousa ,P. Goncalves , J. Fazendeiro , M.T. Parisotto 

1 

Fresenius Medical Care, NephroCare Viseu, Viseu, Portugal 

2 


3 


P 073/O 44 

Impact of needle size and blood flow in on-line haemodiafiltration 

1 1 2 3 4 4 4 4 

V. Fernandez , F. Horrillo , M.T. Parisotto , A.Martinez,L.Pérez,J.Fernández-Caro,M.Ruiz,J.Pinero 

1 

Fresenius Medical Care, NephroCare, Cartagena / San Pedro del Pinatar, Spain 

2 


3 

Fresenius Medical Care, Nursing Care Coordination, Madrid, Spain 

4 

Fresenius Medical Care, NephroCare, Cartagena / San Pedro del Pintar, Spain 

P 074 

Does vascular access type affect to the inflammatory state of haemodialysis patients? 

1 1 1 1 1 

R. Menezo Viadero , M. Garcia Martinez , J.L. Cobo Sánchez , M.E. Cuadrado Mantecón , C. Villa Llamazares , M. 

1 1 1 1 1 

Gandara Revuelta , A. Cano Gil , A. Aja Crespo , M. Herrero Montes , R. Alonso Nates 

1 

Hospital Marques de Valdecilla, Nephrology, Santander, Spain 

ST 


29

POSTER SESSION E Monday 17 September 11:00 - 12:30 

Haemodialysis P 075 – P 096, P 133 

P 076 

Patient safety and quality in treating haemodialysis patients 

1 2 

T. Lönnberg , R. Inkinen 

1 

Tampere University Hospital, Dialysis department, Tampere, Finland 

2 

National institute for health and welfare, Development, Tampere, Finland 

P 077 

Examination of haemodialysis patients' hydration by bio impedance analysis 

1 1 1 

E. Nagy , J. Kantor , I. Kulcsar 

1 

B.Braun Avitum, 6th Dialysis Centre, Szombathely, Hungary 

P 078 

Vitamin D deficiency in patients on haemo- and peritoneal dialysis 

1 1 1 1 

I. Szakacs , L. Kovacs , T. Csitkovics , I. Kulcsar 

1 


P 079 

Examination of body composition of haemodialysis patients by bioimpedance analysis 

1 1 1 

J. Kantor , E. Nagy , I. Kulcsar 

1 


P 080 

Colecalciferol overdose 

1 2 1 

P.Demarchi,C.Sophoclis,O.Dahmani 

1 

CH Louis Jaillon, Nephrology, Saint Claude, France 

2 

CH Louis Jaillon, Secondary care, Saint Claude, France 

P 081 

Mystery of the cephalic arch segment in promoting thrombosis 

1 2 2 1 

P.Demarchi,C.Sophoclis,C.Allers 

, O. Dahmani 

1 


2 


P 082 

Kt/V is a poor predictor of concentration of different uremic toxins 

1 1 1 1 1 

S. Eloot , A. De Cubber , G. Glorieux , N. Neirynck , R. Vanholder 

1 

Ghent University Hospital, Nephrology, Gent, Belgium 

P 083 

The dark side of parenteral nutrution in haemodialysis 

1 2 1 

P.Demarchi,C.Sophoclis,O.Dahmani 

1 


2 


P 084 

How frequent is intradialytic hypertension in end-stage renal disease treated by maintenance haemodialysis? 

1 1 1 1 1 1 1 1 1 

E.Tomescu, M. Cirje ,E.Merla,M.Turcu,F. Barcanescu , V. Georgescu , C. Neacsu , M. Preda , A.Seica,P. 

1 

Gusbeth-Tatomir 

1 

Fresenius Nephrocare, Nephrocare Dialysis Center, Pitesti, Romania 

P 085 

Uniform monitoring documents - a method to optimise patient safety 

1 1 1 

J. Pia ,C.Ahlin , K. Svennerstrand 

1 

Karolinska University Hospital, Dialysis unit, Stockholm, Sweden 

P 086 

Comorbidities and haemodialysis mortality: single center experience in 10 years of follow-up 

1 1 1 1 1 1 1 1 1 

A.Moreci,L.DiMeo,C.Mamone,V.Caracciolo,P.Priori,E.Pucci,M.Pendenza,V.Maggisano,F. 

Della Grotta 

1 

S. Giuseppe hospital, Nephrology & dialysis, Albano Laziale, Italy 

P 087 

Improving the quality of nursing care and the adherence of dialysis patients 

1 1 2 3 

M.M. Machado ,F. Vieira , J. Fazendeiro Matos , M.T. Parisotto 

1 

Fresenius Medical Care, NephroCare, Braga, Portugal 

2 


3 



P 088 

Nutritional characterisation of patients with chronic kidney disease undergoing haemodialysis treatment in Brazil 

1 1 2 3 3 4 5 6 4 

B. Biavo ,C.Machado,L.Cunha,M.Araujo , M. Ribeiro , S. Draibe , E. Barros , J. Santos , A. Sachs , C. Tzanno- 

7 

Martins 

1 

RenalClass, Nutrition, Sao Paulo, Brazil 

2 

UFMG, veterinarian, Minas Gerais, Brazil 

3 

CLINEMGE, Nutrition, Minas Gerais, Brazil 

4 

UNIFESP, Nephrology, Sao Paulo, Brazil 

5 

UFRS, Nephrology, Sao Paulo, Brazil 

6 

Home Dialysis Center, Nutrition, Sao Paulo, Brazil 

7 

RenalClass, Nephrology, Sao Paulo, Brazil 

P 089 

Pregnancy and haemodialysis an holistic team approach 

1 1 1 1 1 1 1 1 1 1 

C. Moreno Aliaga , J. Gonzalez , L. Navarro , A.Martinez,R.Moll,I.Fonfria,F.Tomas,A.Marti,J.F. Martinez , M.A. Munoz 

1 

CHGUV, Nephrology, Valencia, Spain 

P 090 

Nutritional status in haemodialysis patients 

1 2 3 3 

M. Markiewicz ,M.Liber,C.Miriunis,M.T.Parisotto 

1 2 

Fresenius NephroCare, Dialysis Centre, Pulawy, Poland Fresenius NephroCare, Nursing Care, Poznan, Poland 

3 


P 091 

Effect on haemoglobin of the switch from methoxy-polyethylene-glycol-epoetin (Mircera®) to darbepoetin 

(Aranesp®) in haemodialysis 

1 1 1 1 1 1 

L. Rottiers ,P.Wuyts,P. Coppens , B. Segers , G.A. Verpooten , K. Van den Ende 

1 

Antwerp University Hospital, Nephrology-Hypertension, Edegem, Belgium 

P 092 

Haemodialysis nurses profile as outlined by haemodialysis patients of our renal unit 

1 1 1 1 1 1 1 

E. Tsakiridi , A. Karagkouni , A. Mpokari , E. Kapelanos , E. Kokkinou , G. Poulida , E. Sarris 

1 

General Hospital west Attica, Renal unit, Athens, Greece 

P 093 

Changes in lifestyle and social relationship of patients started on haemodialysis therapy 

1 1 

K. Tiroly ,T.Szabo 

1 

B.Braun Avitum Dialysis Network, Dialysis Center #14, Kistarcsa, Hungary 

P 094/O 39 

Dialysis dose scaled to body surface area and patient mortality: results from DOPPS study 

1 2 2 2 3 4 2 2 5 2 

M. Pegoraro , B. Lantz , A.Kapke,J.Pearson,R.Vanholder,T.Tomo,B.Robinson,F. Port , J. Daugirdas , S. Ramirez 

1 

EDTNA/ERCA Italian branch, CAL Corsico -Niguarda Hospital, Milano, Italy 

2 

Arbor Research, Collaborative For Health, Ann Arbor, USA 

3 

University, Hospital, Ghent, Belgium 

4 

Oita, University, Oita City, Japan 

5 

College of Medicine, University of Illinois, Chicago, USA 

P 095/O 41 

Introduction of nocturnal haemodialysis into a home haemodialysis programme 

1 1 1 

G. Williams ,L.Baker,A. Mikhail 

1 

MORRISTON HOSPITAL, Renal Unit, Swansea, United Kingdom 

P 096/O 43 

Exploring the positive impact of physical activeness during dialysis on general state of health 

1 1 2 3 

A.Loncar,S.Drenski,M.Trkulja,C.Miriunis 

1 

Fresenius Medical Care, Polyclinic IDC, Zabok, Croatia 

2 

Fresenius Medical Care, Nursing Care, Zagreb, Croatia 

3 


P 133 

Preventing infections in patients with central venous catheters 

1 2 3 3 

E. Rady ,M.Preda,C.Miriunis,M.T.Parisotto 

1 

Fresenius Medical Care, Dialysis centre "carol davila", Bucharest, Romania 

2 

Fresenius Medical Care, Clinical Coordinator, Bucharest, Romania 

3 

Fresenius Medical Care, NephroCare Coordinator, Bad Homburg, Germany 

ST 


31

POSTER SESSION F Monday 17 September 14:00 - 15:30 

Education of staff/patients P 098 – P 114, P 134 

P 098 

The use of clinical audit to inform change in clinical practice 

1 2 2 

S. Harvey , D. Starbuck , D. Maughan 

1 

Baxter Healthcare LTD, Renal, Berkshire, United Kingdom 

2 

Doncaster and Bassetlow Hospital NHS foundation trust., Renal, Doncaster, United Kingdom 

P 099 

Prevalence of comorbid conditions in elderly patients on haemodialysis 

1 1 1 1 

M. Domiánné Major , K. Tölgyesi , E. Macsai , A.Benke 

1 

B.Braun Avitum, 3rd Dialysiscenter, Veszprem, Hungary 

P 100 

Excellence - a habit not an act: peritoneal dialysis patient training 

1 1 

S. Smith ,N.Baguley 

1 

Baxter Healthcare Ltd, Renal, Newbury, United Kingdom 

P 101 

Influence of structured predialysis education programme on renal replacement therapy modality selection 

1 1 1 1 1 1 1 

B. Poje , S. Vidrih , G. Terlevic , K. Jozic , S. Katalinic , B. Vujicic , S. Racki 

1 

Clinical Hospital Centar in Rijeka, of Nephrology and Dialysis, Rijeka, Croatia 

P 102 

Phosphate binders and the management of phosphate intake and nutrition in chronic kidney disease 

1 

2 

C.I. Bagnis , J.B. Copley 

1 

Universite Pierre et Marie Curie et groupe hospitalier Pitie Salpetriere, Service de Nephrologie, Paris, France 

2 

Shire Pharmaceuticals, Clinical Development and Medical Affairs, Wayne PA,USA 

P 103 

New approach in nurse education in peritoneal dialysis 

1 1 1 1 

R. Balic , M. Kljak , N. Basic Jukic , B. Jelakovic 

1 

University Hospital Centre Zagreb, Department of Nephrology Arterial Hypertension and Dialysis Department 

of Internal Medicine, Zagreb, Croatia 

P 104 

First diagnosed HIT in Croatia in patient on chronic haemodialysis - case report 

1 1 1 1 

G. Erzen , B. Brunetta-Gavranic , M. Maretic-Dumic , N. Basic-Jukic 

1 

University Hospital Centre Zagreb, Department of dialysis, Zagreb, Croatia 

P 105 

Education programme “90 days” 

1 

I. Staskova 

1 

B.Braun Avitum, Dialysis Centre, Prague, Czech Republic 

P 106 

Arm hygiene improvement activity in chronic hemodialysis patients needs correct name 

1 2 3 4 

B. Cetin ,S.Ünver,F. Akdeniz , T. Ecder 

1 

Diaverum Lüleburgaz Dialysis Center, Hemodialysis, Kirklareli, Turkey 

2 

Istanbul University, Health Science Institute, Istanbul, Turkey 

3 

Country Clinical Specialist, Diaverum, Ankara, Turkey 

4 

Istanbul Faculty of Medicine, Department of Internal Medicine Division of Nephrology, Istanbul, Turkey 

P 107 

Pre-dialysis patient education delays the initiation of renal replacement therapy. 

1 1 1 

J. Kantor , I. Szakacs , I. Kulcsar 

1 



P 108 

Methodology to assess competence and to enhance accountability in haemodialysis nurses 

1 1 1 

E. Junyent Iglesias , T.M. Ho Wong , N. Pujolar Fulquet 

1 

Servei de Nefrologia, Hospital del Mar, Barcelona, Spain 

P 109 

Education of disabled patients for peritoneal dialysis therapy 

1 1 1 

T. Kurfis ,S.Bandur,T.Szabo 

1 

B.Braun Avitum Dialysis Network, Dialysis Center #14, Kistarcsa, Hungary 

P 110 

Education of patients with chronic kidney disease stage 5 on haemodialysis 

1 2 3 

D. Znidarko , S. Frumen , C. Miriunis 

1 

Fresenius Medical Care, Training & Education, Zrece, Slovenia 

2 

Fresenius Medical Care, Nursing Care, Ljubljana, Slovenia 

3 


P 111 

A learning resource for water control of fluids to enhance haemodialysis patients' compliance 

1 2 3 4 5 6 7 3 

J.P. Martins ,F. Nisihara , B. Biavo , S. Reis-Caramello , J. Santos , J.C. Rocha , M.C. Brando , C. Barros , C. 

8 8 

Tzanno-Martins , E. Ribeiro Jr 

1 

RenalClass, Psychiatrist, São Paulo, Brazil 

2 

RenalClass, Psychologist, São Paulo, Brazil 

3 

RenalClass, Nutritionist, São Paulo, Brazil 

4 

HDC, Psychologist, São Paulo, Brazil 

5 

HDC, Nutritionist, São Paulo, Brazil 

6 

CINE, Psychologist, São Paulo, Brazil 

7 

CINE, Nutritionist, São Paulo, Brazil 

8 

RenalClass, Nephrologist Head, São Paulo, Brazil 

P 112 

Dialysis nurses' role in improving patients' compliance to phosphate level management 

1 2 3 

S. Calinescu ,M.Preda,C.Miriunis 

1 

Fresenius Medical Care, NephroCare Brasov, Brasov, Romania 

2 


3 


P 113/O 40 

Eleven key areas of renal nurse responsibility - the foundations of quality patient dialysis outcomes 

1 2 3 3 3 3 

A. Bunani , J. Sedgewick , A. Al Lehbi , D.B. Paguia , C. Alferez , J.Ma. John 

1 


2 


3 


P 114/O 45 

Impact of procedure analysis and personnel training on waste generation and resources consumption 

1 1 2 3 

A.Morais,F. 

Gomes , J. Fazendeiro , M.T. Parisotto 

1 

Fresenius Medical Care, NephroCare de Vila Franca de Xira, Vila Franca de Xira, Portugal 

2 


3 


P 134 

Important role of nurse in diagnostics and education of people who are unaware of increased risk 

1 1 1 1 1 1 

M. Mihalic , K. Gojak , M. Ivanisevic , V. Premuzic , B. Jelakovic , M. Laganovic 

1 

University Hospital Centre Zagreb, Dept for Nephrology Hypertension and Dialysis, Zagreb, Croatia 

ST 


33

POSTER SESSION G Monday 17 September 14:00 - 15:30 

Service Management, Quality and Audit 

Psychosocialcare 

Open Forum 

Haemodialysis 

P 116 

Minimisation of ESA therapy post TREAT Study: one year experience 

1 1 1 2 2 1 

C. Wood ,P.D. Wilson , A. Rumjon , S. Khakoo , M. Chai , I.C. Macdougall 

1 

Kings College Hospital, Renal Outpatients, London, United Kingdom 

2 

Kings College Hospital, Pharmacy Department, London, United Kingdom 

P 117 

Job satisfaction in haemodialysis nurses: results from a two country study 

1 1 1 

B. Hayes , A. Bonner , C. Douglas 

1 

Queensland University of Technology, School of Nursing, Brisbane, Australia 

P 118 

Enhancing safe administration of anticoagulation therapy in Saudi Arabia - a challenge in nursing practice 

1 2 3 


1 


2 


3 


P 119 

The power of team-work interventions on diabetic foot wound care 

1 2 3 4 

B. Cetin ,S.Ünver,F. Akdeniz , T. Ecder 

1 

Diaverum Lüleburgaz Dialysis Center, Hemodialysis, Kirklareli, Turkey 

2 

Istanbul University, Health Science Institute, Istanbul, Turkey 

3 

Country Clinical Specialist, Diaverum, Ankara, Turkey 

4 

Istanbul Faculty of Medicine, Department of Internal Medicine Division of Nephrology, Istanbul, Turkey 

P 120 

Patient reported outcomes direct improvement targets in nurse-led chronic kidney disease clinics 

1 1 1 1 1 1 1 1 

D. Gifford ,W.Brown,C.Schmalzhaf, L. Dahri ,K.Pryde,E.Tonkin,H.Watts,M.Griffith 

1 

Imperial College NHS Trust, Renal Services, London, United Kingdom 

P 121 

A working collaboration in north Holland 

1 

S. Rogers 

1 

Codia Waterland, Hemodialysis, Purmerend, Netherlands 

P 122 

Create a safety culture by using clinical incident reporting tool 

1 2 3 3 

C. Popescu ,M.Preda,C.Miriunis,M.T.Parisotto 

1 

Fresenius Medical Care, NephroCare, Bucharest, Romania 

2 


3 


P 123 

Illness perceptions and symptoms in patients with chronic kidney disease 

1 2 1 

A.Pagels, 

B. Klang Söderkvist , S. Heiwe 

1 

Karolinska Institute, Dpt of Medicine Solna, Stockholm, Sweden 

2 

Karolinska Institute, Dpt of Neurobiology Caring Sciences and Society, Stockholm, Sweden 


P 116 – P 122 

P 123 – P 129 

P 130 

P 131

P 124 

Factors related to pruritus in dialysis patients 

1 2 

M. Mollaoglu , B. Yürügen 

1 

Cumhuriyet University, Health Sciences Faculty Nursing Department, Sivas, Turkey 

2 

Okan University, Nursing Department, Istanbul, Turkey 

P 125 

Cultural disparities in haemodialysed patient population: how can we overcome this? 

1 1 1 1 

M. Kreinné Kopacsi , K. Tölgyesi , E. Macsai , A.Benke 

1 rd 


P 126 

The association between social support and psychosocial factors upon mortality and quality of life 

1 2 3 


1 


2 


3 


P 127 

Evaluation of the reasons for the choice of dialysis modality: a pilot study 

1 1 1 

M.P. Fiorito ,G.Cangini,M.P.Zito 

1 

Nefrologia Dialisi e Trapianto Stefoni, Medicina Interna dell'Invecchiamento e Malattie nefrologiche, Bologna, 

Italy 

P 128 

The influence of chronic haemodialysis on patients' quality of life and psychosocial behaviour 

1 1 2 3 4 

D. Viriot , R. Ibos , M. Guedj , J.P. Gassia , C. Miriunis 

1 

Fresenius Medical Care, NephroCare, Muret, France 

2 

Fresenius Medical Care, Le Mirail, Toulouse, France 

3 

Fresenius Medical Care, NephroCare, Paris, France 

4 


P 129 

High prevalence of sexual dissatisfaction in haemodialysis patients 

1 2 3 4 5 6 1 

C. Tzanno-Martins , S. Reis-Caramello , J.C. Rocha , F. Nisihara , J.P.Martins,B.Biavo,E.RibeiroJr 

1 

RenalClass, Nephrologist Head, Sao Paulo, Brazil 

2 

HDC, Psychologist, São Paulo, Brazil 

3 

CINE, Psychologist, São Paulo, Brazil 

4 

RenalClass, Psychologist, São Paulo, Brazil 

5 

RenalClass, Psychiatrist, São Paulo, Brazil 

6 

RenalClass, Nutritionist, São Paulo, Brazil 

P 131 

The results of the patient / nurse partnership 

1 2 3 3 

A. Ungureanu ,M.Preda,C.Miriunis,M.T.Parisotto 

1 

Fresenius Medical Care, dialysis centre "carol davila", Bucharest, Romania 

2 


3 


ST 


35

EXHIBITION 

The industry exhibition of dialysis equipment manufactures and pharmaceutical companies will be held 

st 

in 1 Floor foyer . The latest dialysis related technology and pharmaceutical products are presented that will shape 

the future of renalcare. 

OPENING HOURS 

ACIME FRAME 

Since 1990 Acime Frame designs, produces and sells mobile units for transport and care of patients inside hospitals 

and clinics. Our range is mainly composed of stretchers, care armchairs, transfer chairs, examination couches, 

screens and IV poles. 

The different departments concerned are dialysis, auto-dialysis, blood transfusion and radiotherapy. Based on the 

north of France, we benefit from an industrial culture that allows us to be efficient in our productivity and 

reactivity. Cleaning and using our products is very easy. 

Acime Frame 

1, avenue de l'Europe - Z.A. de la Maie, 62720 Rinxent, France 

Contact person: Nadege Fasquel 

Phone: +33 (0)3 21 10 25 30 Fax: +33 (0)3 21 10 85 90 

Email: contact@acimeframe.com Website: www.acimeframe.com 

ARBOR RESEARCH/DOPPS 

Arbor Research is a not-for-profit research organization based in Ann Arbor, Michigan, USA, conducting large studies 

in epidemiology and public health. With particular expertise in biostatistical analysis, clinical practice, the 

management and integration of large data sets, economics, and public policy, Arbor Research engages in health 

outcomes research on chronic disease and end-stage organ failure, currently including the international Dialysis 

Outcomes and Practice Patterns Study (www.dopps.org). 

BAXTER 

Saturday 15 September 2012 18:00–21:00 

Sunday 16 September 2012 09:00–17:30 

Monday 17 September 2012 09:00–17:30 

LIST OF EXHIBITORS (in alphabetical order) 

Arbor Research Collaborative for Health 

340 East Huron Street, Suite 300, Ann Arbor, MI, USA 

Contact person: Michelle Maxim 

Phone: +1-734-369-9391 Fax: +1-734-665-2103 

Email: michelle.maxim@arborresearch.org Website: www.dopps.org 

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and 

sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and 

other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique 

combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance 

patient care worldwide. 

Baxter Healthcare SA 

Contact person: Brigitte Huhn-Kiele 

Phone: +49 6151 397 29 17 Fax: +49 6151 397 29 33 

Email: brigitte_huhn-kiele@baxter.com Website: www.baxter.com 


BOOTH 21 

BOOTH 20 

BOOTH 13

BELLCO 

Bellco. The right therapy way 

Bellco offers worldwide therapeutic systems for blood purification in Dialysis, Intensive Care, Cardiology. Bellco 

focus is on personalized treatments. Customized therapeutic options are common to the three new devices: 

AMPLYA (Acute); FLEXYA (Chronic); CARPE DIEM (Neonatal). 

Bellco stands out for the Collaborative Research with the goal ofsharing innovation with the medical-scientific 

community. Upon these premises, Bellco provides its contribution to the Collaborative Research Club. 

Complex clinical conditions, such as those of the ever larger number of elderly and critical patients, require an 

integrated and flexible approach. The Bellco’s all-embracing offer provides an innovative outlook on Chronic 

patients. 

Bellco S.r.l. 

Via Camurana, 1, 41037 Mirandola (Modena), Italy 

Contact person: Ms Lorena SGARBI 

Phone: +39 0535 29238 Fax: +39 0535 29407 

Email: lorena.sgarbi@bellco.net Website: www.bellco.net 

BIONIC 

Bionic Medizintechnik with HQ in Friedrichsdorf nearFrankfurt, Germany, is a specialised manufacturer of products 

for dialysis since 30 years. Our product range includes a large selection of dialysis fistula needles, dialysis catheters, 

therapy chairs and beds. 

Bionic dialysis fistula needles are leading in Europe and are setting new standards in quality and puncture 

characteristics. Bionic therapy chairs and beds are leading in performance and ergonomics. 

Bionic Medizintechnik GmbH 

Max-Planck-Str.21, 61381 Friedrichsdorf, Germany 

Contact person: Leo Allegra 

Phone: +49(0)617275760 Fax: +49(0)6172757610 

Email: info@bionic-jms.com Website: www.bionic-jms.com 

EMODIAL 

Emodial Srlwas established in 1982 in Ferrara, Italy, and since that timehas been operating in the field of 

haemodialysis providing a complete range of products for dressings and becoming one the leading companies in the 

field. 

Our products have been designed on the basis of the suggestions and co-operation offered by various Dialysis 

Centres of relevant Care Units, which felt the need for new products suitable for the medications and absorption of 

wound exudates, to be used as an alternative to the traditional cotton or non-woven pads. 

EMODIAL SRL 

Via Finati 4A, 44124-Ferrara, Italy 

Contact person: Gianni Pecorari 

Phone: +39 0532 978198 Fax: +39 0532 978414 

E-mail: info@emodial.it Website: www.emodial.it 

BOOTH 14 

BOOTH 16 

BOOTH 10 

ST 


37

FRESENIUS MEDICAL CARE 

Fresenius MedicalCare is the world's largest integrated provider of products and services for individuals undergoing 

dialysis because of chronic kidney failure, a condition that affects more than 2.1 million individuals worldwide. 

Through its network of more than 3,100 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and 

Africa, Fresenius MedicalCare provides dialysis treatment to more than 256,400 patients around the globe. 

With innovative dialysis products and therapies we define highest standards for the treatment of patients with 

chronic kidney failure. 

Fresenius MedicalCare is the committed partner in renalcare - dedicated to providing complete renalreplacement 

therapy at the point of care. 

Our dialysis centres in Europe, Middle East, Africa and Latin America provide dialysis services in more than 25 

countries with NephroCare as our service brand. NephroCare’s commitment to excellence and the resulting 

comprehensive business model drives us to work closely with the healthcare authorities to ensure affordable renal 

care. Now and in the future, for the maximum possible number of patients. 

Fresenius Medical Care is continuously developing innovative concepts for a sustainable future while focusing on 

proven quality in renaltherapy. 

With the business unit RenalPharma Fresenius MedicalCare is now complementing its leading dialysis technologies, 

products and services with renal pharmaceuticals. We will continuously build up and provide a comprehensive 

range of drugs and drive their integration into innovative treatment platforms to achieve improved therapeutic 

outcomes in dialysis patients. 

Fresenius Medical Care Deutschland GmbH 

Else-Kröner-Str. 1, Bad Homburg v.d.H., 61352, Germany Website: www.fmc-ag.com 

GAMBRO 

Gambro has been pioneering solutions for patients in Chronic and Acute Therapies for more than47years. With you 

and your patients as our inspiration, we are constantly seeking ways to advance the science of dialysis. The result is 

innovative products & therapies that will support your success. 

Gambro – Your home of INNOVATION – You inspire, We innovate. 

Gambro 

Scheelevägen 34, 22010, Lund, Sweden 

Phone: +46 46 16 90 00 Fax: +46 46 16 91 75 

Email: branding.market.communication@gambro.com www.gambro.com 

HERCO WASSERTECHNIK 

HERCO develops and offers complete water treatment solutions for dialysis applications, made in Germany. 

Products are: Water softeners, filters, reverse osmosis, ring main, bed head media panels, central concentrate 

distribution. Reverse osmosis units for haemodialysis purposes according to MDD, TÜV approved 

HERCO Wassertechnik GmbH 

Contact person: Hans Richard Ernst 

Phone: +49 7141 70 95 42 Fax: +49 7141 70 95 99 

Email: Richard.ernst@herco-wt.de Website: www.herco-wt.de 


BOOTH 9 

BOOTH 7 

BOOTH 8

MALMÖ 2013 

Malmö Convention Bureau, the city's official organization for conferences and congresses. We give you free 

information and advice on Malmö, both when to sell in the conference, congress or meeting, and when it is time 

for the planning of all the practical issues associated with the event. 

We help you with advice on appropriate hotel and meeting rooms. We also provide you with suggestions on social 

programs, and provide contacts for professional congress organizers who can take care of all practical 

arrangements. 

Malmö Convention Bureau 

c/o Malmö Turism, Lugnagatan 84, 211 59 Malmö, Sweden 

Contact person: Emma Hänninen 

Phone: +46-(0)70-934 22 42 Fax: +46-(0)40-34 22 11 

Email: emma.hanninen@malmo.se Website: www.malmotown.com 

MEDCOMP 

Medcomp, well known for its wide range of cuffed and uncuffed venous access catheters will be offering 

revolutionary NEWS: 

STERILE PACKED prefilled syringes DURALOCK. 

DuraLock-C’s unique sterile packaging of a prefilled syringe canmake catheter locking a single-handed procedure, 

freeing up staff for other duties. It also makes the procedure needle-free, reducing your risk of sharps injury. 

Medcomp 

1499 Delp Drive, Harleysville, PA 19438 USA 

Contact person: Ruud van Kemenade 

Phone: +1-215-256-4201 Fax: +1-215-256-1787 

Email: ruud@medcompnet.com Website: www.medcompnet.com 

SANOFI 

Sanofi is a diversified global healthcare leader, focused on patients’ needs, we act with our partners to protect 

health, enhance life and respond to the potentialhealthcare needs of the 7 billion people around the world. 

For more information: en.sanofi.com/home.asp 

Sanofi 

54, rue La Boétie, 75008 Paris, France 

Contact person : Christopher Hunter-Ward – Communication Department 

Phone: +33 (0)1 53 77 40 00 Fax: +33 (0)1 53 77 41 33 

Email: christopher.hunter-ward@sanofi.com Website: en.sanofi.com/home.asp 

SHIRE 

Shire shares the vision of nephrology practitioners to place the best interest of patients at the heart of everything 

we do. The commitment of Shire is to enable people with life-altering conditions to leadbetterlives.Inthefieldof 

nephrology, Shire supports research which improves understanding of renal science, kidney health awareness and 

education in renal units. WWW.SHIRE.COM 

Shire AG 

Business Park Terre-Bonne, Route de Crassier 15, 1262 Eysins, Switzerland 

Contact person: Alpesh Joshi 

Phone: +41799619943 

Email: ajoshi@shire.com Website: www.shire.com 

BOOTH 6 

BOOTH 5 

BOOTH 11 

BOOTH 12 

ST 


39

TAUROPHARM 

TauroPharm GmbH is a life science company specialized in antimicrobialmedical devices. One of the company’s core 

interests is to offer a safe and effective technology for locking central venous access devices (catheters and ports). 

TauroLock, a non-antibiotic lock solution, which is capable of dramatically reducing catheter related blood stream 

infections (CRBSI) is free of side-effects. TauroLock is highly effective in eradicating bacteriaand fungi and has 

been successfully tested on more than five hundred organisms, including multiresistant forms such as MRSA and 

VRE. It is to be used in dialysis, oncology, intensive care and parenteral nutrition. 

To improve catheter patency TauroLock products contain 4% citrate and/or heparin (TauroLock, TauroLock- 

Hep100, TauroLock-Hep500) and/or urokinase (TauroLock-U25.000). 

TauroPharm GmbH 

Jägerstr. 5a, D-97072 Waldbüttelbrunn, Germany 

Contact person: Andrea Glaser 

Phone: +49 – 931 – 40 48 05 11 Fax: +49 – 931 – 40 58 78 

Email: infos@tauropharm.de Website: www.taurolock.de 

TELEFLEX MEDICAL 

Teleflex is a leading global provider of specialty medical devices used for diagnostic and therapeutic procedures in 

critical care, urology and surgery. Our mission is to provide solutions that enable healthcare providers to improve 

outcomes and enhance patient and provider safety. 

Our vascular access product range includes the well-known Arrow dialysis access devices for acute and chronic 

haemodialysis. It extends from a line of antiseptic products with ArrowGard Blue impregnation for acute dialysis, over 

haemodialysis catheters to be positioned by retrograde and antegrade tunneling technique, up to an advanced PTDsystem 

for effective shunt and fistula thrombus cleaning. 

Teleflex Medical Europe Ltd 

IDA Business and Technology Park, Garrycastle, Dublin Road, Athlone, Co Westmeath, Ireland 

Contact person: Customer Service 

Phone: +353 (0) 9 06 46 08 00 Fax: +353 (0) 14 37 07 73 

Email: orders.intl@teleflex.com Website: www.teleflex.com 

TERUMO BCT 

Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, is the only 

company with the unique combination of apheresis collections, manual and automated whole blood processing, 

and pathogen reduction coupled with leading technologies in therapeutic apheresis and cell processing. We believe 

in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and 

strengthens our collaboration with customers. 

Terumo BCT Europe N.V. 

Contact person: Eve Labar 

Phone: +32 2 7150590 Fax: +32 2 7210770 

Email: info.emea@terumobct.com Website: www.terumobct.com 


BOOTH 4 

BOOTH 15 

BOOTH 18

EXHIBITION FLOORPLAN 

LIST OF EXHIBITORS 

EXHIBITOR BOOTH 

ACIME FRAME 21 

ARBOR RESEARCH 

COLLABORATIVE FOR HEALTH 20 

BAXTER 13 

BELLCO 14 

BIONIC 16 

EDTNA/ERCA 22 

EMODIAL 10 

FRESENIUS MEDICAL CARE 9 

GAMBRO 7 

HERCO WASSERTECHNIK 8 

MALMÖ 2013 6 

MEDCOMP 5 

SANOFI 11 

SHIRE 12 

TAUROPHARM 4 

TELEFLEX MEDICAL 15 

TERUMO BCT 18 

5 

6 

4 

7 

8 

ERASME 

HALL 

9 

20 

16 

15 

14 

10 

18 

12 

21 

11 

22 

TIVOLI 1 

TIVOLI 2 

13 

SCHUMAN 

HALL 

ST 


41

PRACTICAL INFORMATION A-Z 

A 

ABSTRACT BOOK 

The Abstract Book will be distributed on USB in 

electronic version only. 

Each delegate will receive and Abstract Book voucher 

during Registration to pick up the Publication atGambro 

stand no.7 in the Exhibition area. 

ACCREDITATION OF LEARNING HOURS 

CME CREDITS 

st 

The 41 EDTNA/ERCA International Conference is 

accredited by the European Accreditation Council for 

Continuing Medical Education (EACCME) to provide the 

following CME activity for medical specialists (UEMS), 

www.uems.net. 

This years’ Conference has been allocated a maximum 

of 15 hours of Europeanexternal CME credits. 

Each medical/healthcare specialist should claim only 

those hours of credit that he/she actually spent in the 

educational activity. These will be recorded via a 

barcode that will track your attendanceinlecturehalls. 

Please note each participant is responsible to ensure 

his/her barcode is scanned on entry and exit of a 

session. 

1 credit will be assigned for each session (1 session 

per time slot, minimum 30 minutes spent in the 

session hall). 

A Certificate of attendance will be provided together 

with CME certificate on the last day of the 

Conference or you can apply via email at 

certificates2012@edtnaerca.org. B 

BADGES 

Each participant will receive a name badge at 

registration. Badges must be worn at all times to enable 

session attendance to be tracked for education 

accreditation. On the badge is a barcode which is 

scanned on entering each session hall. CME credits will 

be assigned according to information received from the 

barcode system. This record is also used for safety 

reasons to record participants in the building in case of 

anemergency. 


Therefore it is important you present your badge with 

barcode ateach session hall. 

BOAT TRIP 

Monday, 17 September 

Tuesday, 18 September 

COMPLIMENTARY 

PART OF THE REGISTRATION FEE 

SUPPORT FROM THE CITY 

OF STRASBOURG 

DO NOT MISS THE OPPORTUNITY TO EXPLORE THE 

BEAUTY OF PETITE FRANCE, THE UNESCO HERITAGE 

Boats are equipped with multilanguage audio system 

(13 languages). The trip takes approximately 1 hour and 

15 min. You will be dispatched at the city centre boat 

station. To be eligible for this tour you need to have a 

voucher received during registration. 

Navigation to the departure point - see cover page map. 

C 

DELEGATE GUEST SPEAKER 

VOLUNTEER EXHIBITOR 

COFFEE BREAKS AND LUNCHES 

Coffee breaks and lunches (lunch boxes) are included in 

the registration fees and will be served at the Exhibition 

Area. A lunch box will be provided upon presentation of 

a valid voucher on Sunday (16.9.)and Monday (17.9.) 

only. 

CONFERENCE BAGS 

PRESS INDUSTRY VIP 

ACCOMPANYING PERSON STAFF 

Kindly sponsored by 

Please collect the Conference bag with your exchange 

voucher (received with your badge during your 

registration) at the Conference bag counter in the 

Registration area. 

CONFERENCE LANGUAGE 

Official language is English, however plenary sessions 

and sessions held in the Erasme Hall will be translated 

from English into French, German and Spanish as the 

Conference is organised by an International Scientific 

Association. 

Note that the CES sessions organised by Fresenius Medical 

Care will also be translated into Czech language.

CONFERENCE PATRON 

The Conference is held 

under the patronage of 

Ville et Communauté urbainedeStrasbourg. 

D 

DATE 

Saturday, 15 September – Tuesday, 18 September 2012 

E 

EDTNA/ERCA CONFERENCE DEPARTMENT 

Acontact person for EDTNA/ERCA will be available at 

the Registration Area if required. 

EDTNA/ERCA 

See page 53. 

EVALUATION FORM 

To assist in the continual improvement of the 

Conference please take the time to complete the 

Conference evaluation form provided by the entrance 

to the halls or at EDTNA/ERCA booth. Please return the 

completed form to the EDTNA/ERCA booth or 

Registration desk. 

HOTEL 

If you need any assistance finding a hotel or in case of 

any discrepancies, complains or any other problem in 

regard to your current hotel booking please kindly 

contact an Accommodation desk within the Registration 

Area. OurStaff will do their best to help you with any 

arrangement during scheduled Opening hours. 

New reservations - conditions: 

Rooms are upon request from particular hotels;total 

cost must be paid to the Accommodation desk upon reconfirmation 

of the rooms and no cancellation/no 

reduction of stayisallowed once re-confirmed. 

INSURANCE 

MEMBERSHIP FEES 

EMERGENCY NUMBER 

Dial 112 and ask for the emergency service you require. 

H 

II 

The organisers do not accept liability for personalinjury 

or loss or damage to private property of delegates and 

accompanying persons, either during or while travelling 

to and from the 

st 

41 EDTNA/ERCA International 

Conference. 

INTERNET 

Free WiFi Internet is available to all participants in 

public areas (foyers, corridors) of the venue. 

Network name: Conference 

No key or password required. You will need to accept 

conditions before use. Please note that the number of 

simultaneous connections is limited. 

L 

LOST AND FOUND 

Lost property can behanded in or collected at the 

Information desk located in the Registration Area. 

M 

MESSAGES 

Amessage board will be located in the Registration 

Area.Youcan post your messages here. 

MOBILE PHONES 

Delegates are kindly requested to keep their mobile 

phones in the off position in the meeting rooms while 

sessions are in progress. 

P 

POSTER AREA 

The poster area is located on the ground Floor A. For 

more information about posters see page 22. 

PHOTO 

No photo allowed during scientific sessions. 

See page 11. 

PUBLIC TRANSPORT TICKETS 

This ticket is valid on trams and buses, for an unlimited 

number of journeys. 

3 DAY TICKET 

Valid from 15 September 2012 (04.00 h) until 18 September 

2012 (00.30 h). The price consists of 6,30 EUR ticket (insteadof 

9,30 EUR - special EDTNA/ERCAparticipant discount) + 1 EUR 

handling fee. 

4 DAY TICKET 

Valid from 15 September 2012 (04.00 h) until 19 September 

2012 (00.30 h). The price consists of 9,30 EUR ticket (insteadof 

12,40 EUR - special EDTNA/ERCAparticipant discount) + 1 EUR 

handling fee. 

ST 


43

R 

REGISTRATION 

REGISTRATION OPENING HOURS 

All documents including registration packs canbepicked 

up by registered delegates during the following opening 

hours: 

REGISTRATION FEES 

FEE 

Late/Onsite Registration 

(after 30 August 2012) 

Member 

Non-member 

Student 

Accompaning person 

Saturday 

Sunday 

Monday 

Tuesday 

WITHOUT VAT 

460,70 

580,27 

170,57 

100,33 

15 September 

10:30 – 20:00 

16 September 07:30 

– 18:00 

17 September 08:00 – 17:00 

18 September 08:00 – 14:00 

VAT 

90,30 

113,73 

33,43 

19,67 

TOTAL 

551 

694 

204 

120 

All above rates are in EUR. VAT 19,6 % is applicable for all Conference registration fees and will be charged in general 

on top of the net registration fee. Registration Fees paid by all Companies having a French VAT number are matter of 

Reverse Charge regulation, Conference Department must receive the French VAT number for the preparation of the 

invoice, the amount ex or net of French VAT is to be paid, wrongly paid French VAT 19,6 % will be refunded. 

REGISTRATION FEE INCLUDES 

Participant registration 

fee includes: 

� Admission to Scientific sessions, exhibition and poster area 

� Conference bag, Final Programme, Abstract Book 

� Coffee breaks, 2 x lunch box (16 and 17 September 2012) 

� Admission to Opening Ceremony and Welcome Cocktail 

� Boat trip – you need to sign up for the boat tripat the 

registration. There is limited number of places for each boat. 

Accompanying person registration 

fee includes: 

� Access to Opening Ceremony and Welcome Cocktail 

(Saturday, 15 September 2012) 

� City tour on 17 September 2012 at 10:00 

� Please note that accompanying persons are not allowed to 

attend the scientific sessions or access to the exhibition 

� Boat trip – you need to sign up for the boat tripat the 

registration. There is limited number of places for each boat 

CANCELLATION/REFUND POLICY 

Please note, that for cancellation received after 

15 August 2012 no refund canbeprocessed. 

� All cancellations must be notified in writing (by mail, fax or 

email) to the Conference Department according to the 

following conditions. 

� Refunds will be processed AFTER the Conference. 

� Requests for refunds made after 31 October 2012 will not be 

considered. 

� Registrants may transfer their registration to a colleague at 

any time. For change of name a feeof€50willbecharged. 

� Lost badge – 100EUR fee will be charged 

� All registrations received by 30 August are included in the List 

of participants. 


S 

SIMULTANEOUS TRANSLATION 

The headsets canbecollectedand must be returned at 

the Headsets Desk in the Registration Area. Official 

language is English, however plenary sessions and 

sessions held in the Erasme Hall will be translated from 

English into French, German and Spanish. 

Note that the CES sessions organised by Fresenius Medical Care 

will also be translated into Czech language. 

SMOKING 

Smoking is forbidden in all Conference areas. 

SPEAKERS PREVIEW ROOM (PRESIDENT) 

st 

The Speakers Preview room is located on 1 Floor and 

will be available for guest speakers/delegates making 

an oral presentation. Our staff will be happy to assist 

you. Presentations must be handed in at theSpeakers 

Preview room at least one hour before their session 

start. Speakers will have the opportunity to check their 

presentations on PC's availableintheSpeakers Preview 

room. All lecture rooms are equipped with a presenting 

notebook and data projector for presentations. 

SOCIAL PROGRAMME 

Please see page 45 for further details on the social 

programme.

SOCIAL EVENTS 

OPENING CEREMONY,WELCOME COCKTAIL &EXHIBITION OPENING 

17:00 - OPENING CEREMONY,ERASME HALL 

18:00 - WELCOME COCKTAIL &EXHIBITION OPENING 

Apart of the scientific lecture do not miss the opportunity to see the show of acrobatic duo Daemen - national 

talent show winners 2010 and LasVegasperformers. The Official Opening of the exhibition will immediately follow the Opening Ceremony. 

A Welcome Cocktail will be offered in the Exhibition Area to all delegates and exhibitors (included in the delegates' 

and accompanying persons' registration fees). 

DJ will try to make your time as enjoyable as possible. 

ST 


45

ABOUT EDTNA/ERCA 

The European Dialysis and Transplant Nurses Association/European Renal Care Association (EDTNA/ERCA) was 

established in 1971 to address the specialeducational needs of nurses and other healthcare professionals caring for 

patients who suffer from chronic kidney disease. This includes all aspects of renaltreatment: prevention and early 

detection of chronic kidney disease, management of dialysis therapy, transplantation and supportive care. Since 

then, the Association has grown to become one of the most important forum in Europe for the exchange of 

information and experience for allmembers of the renalcare teamwhotreatand care for patients suffering from 

renalfailure. 

EDTNA/ERCA is a multi-disciplinary organisation of individual members. The Association membership is open to 

nurses, technicians, social workers, dieticians, unit managers, transplant co-ordinators, and any other professionals 

working with renalpatients. EDTNA/ERCA has currently over 2000 members from more than 72 countries. 

EDTNA/ERCA ORGANISATION 

Key Members 

Link Members 

Italian Branch 

EKHA Quality Management 

& Secretariat 

Coordinator 

National & International 

Representation 

Projects 

DOPPS 

International 

Link Members 

Collaborating 

Associations 

ENRCA 


EDTNA/ERCA Members 

more than 2000 from 72 countries 

Finance 

Coordinator 

Project Groups 

& Consultants 

- Anaemia 

- Nutrition 

- Social Work 

- CKD 

- PD 

- Education 

- Transplant 

Executive Committee 

Conference 

Team 

Scientific 

Programme 

Committee 

LOC 

Local Organising 

Committee 

Secretariat, 

Membership & 

Website 

Management 

Conference 

Department & PCO 

Newsletter 

Corporate 

Members 

Executive 

Director 

Industry 

Advisory Board 

Publications 

Books 

Journal 

of Renal Care

The EDTNA/ERCA has expert clinician-based volunteers from a variety of healthcare fields. The volunteers are 

working collaboratively through project groups supported by Consultants 

in the following areas: 

Anaemia, Nutrition, Social Workers, Peritoneal Dialysis, CKD, Education, Research and Transplantation. 

The aim is to develop a network of professionals to share their knowledge and expertise, developing education 

materials, initiating research projects and developing publications as a support tool in the training of staff members 

in renalunits. OUR CONSULTANTS ARE: 

CKD Consultant 

Anaemia Consultant 

Nutrition Consultant 

Social Workers' Consultant 

Peritoneal Dialysis Consultant 

Education Consultant 

Transplant Consultant 

Karen Jenkins (UK) 

Lesley Bennett (UK) 

Liana Poulia (Greece) 

Nurith Blumenthal(Israel) 

Aase Riemann (The Netherlands) 

John Sedgewick (UK) 

José Luis Cobo Sanchéz (Spain) 

Further information about Consultants projects is available attheassociation website www.edtnaerca.org. 

KEY AND LINK MEMBERS 

st 

We encourage you to visit the EDTNA/ERCA booth (nr. 22) located in the Exhibition Area(1 floor foyer) and to bring 

your colleagues with you. The Key and Link Members present will be more than happy to help you with any 

language problems, contacting other Members from your country through a message board and learning more 

about the Association and its activities. In addition, do not forget to look at the informative Key and Link Member 

electronic posters on the website. 

English: If you need any help in your own 

language, please visit the EDTNA/ERCA Key 

Members Booth. 

Italian: Se desidera ulteriori informazioni 

in lingua italiana siamo pronti ad aiudarla 

nello stand EDTNA/ERCA Key Members. 

French: Si vous avez besoin d’aide dans 

votre langue, visitez le stand de 

l’EDTNA/ERCA Key Members. 

Czech: Vpřípadě, že potřebujete asistenci 

v českém jazyce, zastavte se u 

EDTNA/ERCA stánku. 

German: Wenn Sie Assistenz und Hilfe in 

Ihrer eigenen Sprache wünschen, wenden 

Sie sich bitte an den EDTNA/ERCA Key 

Member Stand an. 

Spanish: Si necesita ayuda en su propio 

idioma, por favor visite el stand del Key 

Member de la EDTNA/ERCA. 

Greek: ΕΛΛΗΝΙΚΑ: Εάν χρειάζεστε βοήθεια 

στη γλώσσα σας παρακαλώ επισκεφθείτε 

το περίπτερο των Key Member της 

EDTNA/ERCA. 

List of Key and Link Members on the next page >> 

ST 


47

KEY MEMBERS 

Marianna Eleftheroudi Key Member Mentor vlaxavasg@the.forthnet.gr 

Michel Roden (ad interim) Belgium michel.roden@skynet.be 

Jitka Pancířová (ad interim) Czech Republic pancirova@volny.cz 

Carmen Reiher Germany ca.re@web.de 

Marianna Eleftheroudi Greece vlaxavasg@the.forthnet.gr 

Edita Noruisiene Lithuania nor.edita@gmail.com 

Lina Shwarz Israel linash@clalit.org.il 

Maria Patrizia Fiorito Italy mariapatrizia.fiorito@gmail.com 

Sonja Pecolar Slovenia sonja.pecolar@sb-sg.si 

Calota Hidalgo Lopez Spain chidalgo@parcdesalutmar.cat 

Ursula Dietrich 

LINK MEMBERS 

INTERNATIONAL LINK MEMBERS 

Switzerland ursuladietrich@gmx.ch 

Lyn Allen United Kingdom lyn. allen@nhs.net 

Bozica Stupar Serbia bokizemun@eunet.rs 

Martha Girak Austria martha.girak@meduniwien.ac.at 

Berislav Poje Croatia berislav.poje@gmail.com 

Viktoria Szlonkai Hungary viktoriaszlonkai@fmc-ag.com 

Frank Alexander Kelly Ireland f.kelly@st-vincents.ie 

Gabriela Magrian Poland motzkin@hotmail.com 

Sophie Halldin Sweden 

sophie.halldin@ds.se 

Susan Rogers The Netherlands susan.rogers@xs4all.nl 

Senay Özer Özkan Turkey senayozer@msn.com 

Angela Henson Australia angela_henson@health.qld.gov.au Mary Clare O'Gara China maryog@gmail.com 

Mohammed Shami Al Jondeby Kingdom of Saudi Arabia jondeby@gmail.com 48 FINAL PROGRAMME | WWW.EDTNAERCA.ORG

EDTNA/ERCA KEY MEMBER BOOTH 

Attended by the Key Members/Link Members representing different countries, the Key Member Booth located in 

the exhibition area ( no. 22) 

provide a focus for disseminating information regarding Association activities. A Key 

Member/Link Member from your own country will be available to asnwer your questions or solve any problem. 

Use 

the available message board to contact colleagues at the Conference. 

RAFFLE AT EDTNA/ERCA BOOTH 

Go for the chance to win a pack of 5 EDTNA/ERCA handbooks of your choice. 

Pick up the raffle ticket at the 

EDTNA/ERCA booth and participate in the raffle. 

Where: EDTNA/ERCA booth at the exhibition floor 

When: 15 September & 16 September, every morning and afternoon coffee break 

For: All delegates 

EDTNA/ERCA HANDBOOKS 

EDTNA/ERCA handbooks published in previous years will be available in different languages at the this year 

Conference in Strasbourg. The handbooks will be distributed to EDTNA/ERCA members upon presentation of the 

membership ID number at the EDTNA/ERCA booth or will be sold to non-members for a flat price 15€. 

Do not miss the opportunity to complete your series of „A Guide To ClinicalPractice“. 

Where: EDTNA/ERCA booth at the exhibition floor 

When: 15 September 18:00 – 21:00 

16 September 9:00 - 17:30 

17 September 9:00 - 17:30 

For: 15€ for non-members, EDTNA/ERCA members for free 

List of available books: 

� Renal Transplantation, A Guide to Clinical Practice (English) 

� Peritoneal Dialysis, A Guide to Clinical Practice (English, Dutch, Spanish) 

� Conservative Management in Advanced Kidney Disease, A Guide to Clinical Practice (English) 

� Environmental Guideline for Dialysis, A Practical Guide to reduce the environmental burden 

of dialysis (English) 

� The Diabetic Patient and Chronic Kidney Disease, A Guide to Clinical Practice (English) 

� Caring for the Elderly Renal Patient, A Guide to Clinical Practice (English) 

� Fármacos en Terapia Renal Sustitutiva, Guía de Práctica Clínica (Spanish) 

� Chronic Kidney Disease (1-3 stages) (Italian, Spanish, Turkish) 

� Chronic Kidney Disease (4-5 stages) (Italian) 

� Guideline for Applied Hygiene in Dialysis Units (English) 

� V&A Brochure (English) 

ST 


49

EDTNA/ERCA PUBLICATIONS 

Throughout the year the EDTNA/ERCA puts out two quarterly publications: the Journal 

of RenalCare (JoRC) and the EDTNA/ERCA Newsletter. 

The Journal of Renal Care publishes a broadrange of peer reviewed clinical, research, 

educational and profession oriented material for renalcare professionals. 

The EDTNA/ERCA EditorialBoard seeks to provide content that is relevant and reflective 

of the growing diversity of the renal care community. In addition to the 4 issues, the 

JoRC also offers monothematic supplements that focus on a particular topic of renal 

care. 

The EDTNA/ERCA quarterly Newsletter offers updated information on the Association’s 

activities, projects and events. Its content is complemented with educational reports 

and articles. Contributions come from volunteers and Committee or Board Chairs; 

however, contributions are not exclusive to volunteers. The Newsletter provides an 

opportunity for any multi-disciplinary member to communicate relevant news from 

their own country and to make suggestions. In addition to the hard copies, PDF versions 

are availableonthewebin15differentlanguages. We hope to continue offering this 

service in asmany languages as possible, so thatlanguage does not stop members from 

being well informed. 

During the last 5 years the EDTNA/ERCA has been developing a publications strategy 

that allows the Association to publish at least one handbook 

per year and make it 

available to all members. These handbooks are usually launched at the annual 

conferences. 

This year, 2012, the EDTNA/ERCA has chosen to develop the following handbooks: 

� Acute Kidney Injury, A Guide to Clinical Practice 

� Drugs in Renal Replacement Therapy, A Guide to Clinical Practice 

� Nutritional Care for Adults with Chronic Kidney Disease, 

A Guide to Clinical Practice 

Moreover 

� Environmental Guidelines for Dialysis, A Practical Guide to Reduce the Environmental Burden of Dialysis 

has been translated into 6 languages (Czech, Italian, Spanish, Russian, French, Portuguese). 

DON’T MISS OUT ON THE OPPORTUNITY TO GET A COPY OF THESE BOOKS 

ST 

AT THE 41 EDTNA/ERCA INTERNATIONAL CONFERENCE IN STRASBOURG! 

The EDTNA/ERCA Handbooks launched on previous annual conferences 

will be available at the EDTNA/ERCA booth 

for distribution to EDTNA/ERCA members or for sell to non-members for a flat price of 15€ per hardcopy. 

See page 49 for details about available books. 


CORPORATE MEMBERS 

The companies listed on this page embrace the EDTNA/ERCA’s objective of improving the quality of care given to 

nephrology patients. Their active participation and support of Association activities throughout the yearisthebest 

evidence of our shared commitment. We are proud to acknowledge them as Corporate Members of our Association 

and look forward to further collaboration in the future. 

Amgen Europe Ltd. Switzerland 

Baxter Europe Belgium 

B.Braun Czech Republic 

Diaverum Sweden 

Fresenius MedicalCare AG Germany 

Gambro Sweden 

KfH Kuratorium für Dialyse Germany 

und Nierrentransplantation e.V. 

Lauer MembranWassertechnik GmbH Germany 

Patienten-Heimversorgung Germany 

Redsense Medical, AB Sweden 

Roche Czech Republic 

Sanofi (Genzyme Europe BV) France 

Shire 

UK 

Corporate Membership is open to any company sharing the interests of EDTNA/ERCA and the renal care team. 

CORPORATE MEMBERS 

For more information visit: www.edtnaerca.org/corporate 

PHV-Der Dialysepartner 

Patienten-Heimversorgung Gemeinnützige Stiftung 

ST 


¨ 

51

BECOME A PART OF EDTNA/ERCA COMMUNITY 

As an EDTNA/ERCA Member you will benefit from sound professional support, professional knowledge exchange and 

numerous personallearning opportunities on a national and international level. 

� Stay informed about the latest renal care treatment developments and the Association's activities at a 

national and international level through the EDTNA/ERCA quarterly Newsletter, EDTNA/ERCA eBlast, web 

and 

annual conference. 

� Every yeartheNewsletter layout reflects the annual conference 

Theme and Location. 

® 

� Receive four editions per year of the EDTNA/ERCA JournalofRenalCare plus special Journal Monographs 

� Access project reports of European-wide interest information on Standards and Quality 

Management in RenalCare through the www.edtnaerca.org. 

� Obtain copies of EDTNA/ERCA Handbooks 

- PeritonealDialysis, A Guide to ClinicalPractice 

- Haematology, A Guide to ClinicalPractice 

- RenalTransplantation, A Guide to ClinicalPractice 

- CKD Stage1–3&CKDStage 4–5 

- EDTNA/ERCA Recommendations for Prevention and Management of Violence and Aggression in RenalUnits 

- Conservative Management in Advanced Kidney Disease, A Guide to ClinicalPractice 

- The Diabetic Patient and Chronic Kidney Disease, A Guide to ClinicalPractice 

- Caring for the Eldery RenalPatient, A Guide to ClinicalPractice 

- Environmental Guideline for Dialysis, A Practical Guide to Reduce the EnvironmentalBurdenofDialysis 

- Fármacos en Terapia Renal Sustitutiva, Guía de Práctica Clínica (Spanish) 

... and many more available in the EDTNA/ERCA Publications Portfolio on the Association’s website! 

� Participate in International Conferences and meetings with special member's only conditions. 

Join the EDTNA/ERCA Volunteers' Team and take part in Europeanrenalcare quality advancement. 

� Participate in Projects like: 

- Go Green in Dialysis 

- Vascular Access Cannulation & Care Guidelines 

- DOPPS 

- Venous Needle Dislodgement (VND) 

- Survey on Attitudes of the EuropeanRenalNursesTowards Older People 

- IV Iron Resource and Utilization in Patients with Iron Deficiency Anaemia in CKD 

- IQD (Individualized Quality-assured Dialysis) - A Guide to Implementing RenalBestPractice in Haemodialysis 

- ENRCA Project 

- Survey on Attitudes of the EuropeanRenalNursesTowards Older People 

- Challenges & Opportunities for Renal Care Across Europe – A survey of National Presidents of Renal Health 

Care Associations 

� Speaking your Language: 

- EDTNA/ERCA currently translates the Newsletter in 15 languages (Czech, Dutch, English, French, Greek, 

German, Italian, Lithuanian, Polish, Portuguese, Russian, Serbian, Slovenian, Spanish, Turkish ). Benefit from local 

support from your national Key Member/Link Member and/or International Link. Member Network with peers 

atthenational and international level through local Conferences, Seminars and Project Groups. 

HOW TO JOIN 

You may register online and evaluate which membership category best suits your interests at: www.edtnaerca.org. 

You may also contact Tomáš Nejedlý, the EDTNA/ERCA Membership Manager at queries@edtnaerca.org. 

Please note that membership registration will be processed upon receipt of payment. To contact your national 

EDTNA/ERCA representative (Key Member/Link Member), visit the Leadership Directory on www.edtnaerca.org. 


EDTNA/ERCA ON TWITTER -STAY UP TODATE 

Since January 2012 EDTNA/ERCA has joined the Social Mediaby opening own TWITTER 

account. With almost daily tweeting, EDTNA/ERCA spreads the news about what is going on in 

EDTNA/ERCA aswellasinforms about the most recent facts from the renal field. Follow every 

day the EDTNA/ERCA on Twitter at http://twitter.com/EDTNAERCA and find out whatisgoing 

on… Enjoy new ways of communication with EDTNA/ERCA!!! 

CONFERENCE MEMBERSHIP 

Conference Membership will be granted to any individual who showed interest in renal care and attended the 

International EDTNA/ERCA Conference and who are NOT already member according to another membership 

category. Conference members will have (1) year Conference Membership status and will benefit from electronic 

and print information services at the discretion of the Association. 

MEMBERSHIP FEES 

Member (M-MB) 

European EEC* Member (M-EEC) 

Associate Member** (M-ASC) 

Global Member** (M-GMB) 

* Eastern European Countries: Albania, Belarus, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, 

Hungary, Latvia, Lithuania, Republic of Macedonia, Moldova, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, 

Slovenia, Ukraine. 

** Associate Members, Associate e-Members, Global Members, Global e-Members and Corporate Members do not have 

voting rights. 

EDTNA/ERCA SECRETARIAT 

Prague Congress Centre 

5. května 65 

140 21 Prague 4 

Czech Republic 

Tel.: +420 261 174 318 

Fax: +420 261 174 318 

E-mail: queries@edtnaerca.org 

Web: www.edtnaerca.org 

1 YEAR 

€60 

€20 

€60 

€ 100 

3 YEARS 

€170 

€60 

€170 

€255 

E-MEMBERSHIP FEES 

eMember (ME-MB) 

European EEC* e-Member (ME-EEC) 

Associate e-Member** (ME-AS) 

Global e-Member** (ME-GM) 

1 YEAR 

€40 

€10 

€40 

€40 

3 YEARS 

€ 100 

€30 

€ 100 

€ 100 

ST 


53

A-Z INFORMATION ON ALSACE,FRANCE 

ALSACE 

This bicultural and bilingual regionatthe junction of 

France and Germany is an economic and scientific 

powerhouse as wellas theoptimal platform for driving 

pan-European business development. 

Ideally located at the crossroads of France, Germany 

and Switzerland, Alsace is a land of cultural and 

commercial exchange. The region enjoys a good 

balance between nature and urbanization, and quality 

of life is an asset valued both by the local inhabitants 

and tourists. 

The heritage in Alsace is particularlyrich,especially for 

thenumberofoldcastles and fortified towns, aswellas 

remnants of the industrial revolution. It reflects the 

strong identity of the region, forged over the centuries. 

Contemporary culture also holds an important place in 

Alsace as attested to by the numerous museums, 

amusement parks, theatres and auditoriums. 

GASTRONOMY AND FINE WINES 

Then, there is the art of gastronomy that has been 

generously refined over the centuries. And to 

accompany a great meal, the ‘grand cru’ of Alsace is 

perfectly adapted to local dishes. The finest wines are 

on the wine lists of the world’s best restaurants. 

CULTURE AND HERITAGE 

More than 250 museums and collections throughout 

Alsace look forward to welcoming visitors keen to 

discover their rich heritage, ranging from prehistory 

through to contemporary art. 

Alsace boasts Europe's highest concentration of feudal 

castles, bearing witness to its turbulent history. Without 

a doubt the most famous of these is the Haut 

Koenigsbourg castle which is one of France's most 

frequently visited monuments. Alsace has more than 

400 ruined castles, including the recently restored 

Hohlandsbourg castle. 

The region has also been heavily marked by warfare 

throughout the ages. The Alsace-Moselle Memorial 

traces the tragic history of the Alsace and the Moselle 

areas from 1870 through to Franco-German 

reconciliation and the beginning of the European 

construction process. The Struth of concentration camp 

(the only camp of its kind built on French soil) and the 

Maginot Line including in particular the “Four Chaux” 

fortifications in Lembach bear witness to the region's 

tragic history. 


CURRENCY 

EURO - France joined 11 other EU members to launch 

the Euro on 1 January 1999, with Euro coins and 

banknotes completely replacing the French Franc in 

early 2002. 

EMERGENCY - SOS 112 

The number 112 can bedialled to reach emergency 

services - medical, fire and police - from anywhere in 

Europe. This Pan-European emergency number 112 can 

be called from any telephone (landline, pay phoneor 

mobile cellularphone). 

Calls are free. It can be used for any life-threatening 

situation. 

ELECTRICITY 

Electricity in France is 230 Volts, alternating at 50 cycles 

per second. 

Plug type: Two round pins plugs. 

LANGUAGE 

French - The Alsatian dialect is used throughout the 

whole of Alsace aswellisinpart of the Moselle area.It 

is one of the most widely spoken regional languages in 

France. It is also a key aspect of the region's identity, 

being the result of Alsace's turbulent history. Unlike 

several decades ago, today you won't find any Alsatian 

under the age of 60 unable to speak French, as the 

French language became compulsory at school after the 

liberation. Unfortunately, the transmission of the 

Alsatian language from one generation to another is in 

constant decline, particularly in urban areas. 

Although originally derived from Alemannic, the Alsatian 

dialect is clearly distinct from German. Firstly because 

this is above all a spoken language. Secondly, because 

Alsatian has not evolved in the same manner as 

German, having absorbed a number of words from the 

French language. Although spoken in a relatively limited 

area,theAlsatiandialect varies from place to place.

NATURE 

Asmall region with a huge natural diversity.Thanks to its 

varied climatic influences, Alsace possesses a number of 

very different natural environments guaranteed to 

capture the imagination of anyone who enjoys rural 

tourism or waterborne tourism. Alsace possesses a 

generous and abundant natural environment, including 

the Rhenish jungles on the Rhinauisland, the plains with 

their parks and gardens, the abundant forests including 

the Erstein Forest, or the outstanding biological diversity 

to be found in Alsace's Petite Camargue. 

SMOKING 

France has banned smoking in all public places from 

February 2007. 

STRASBOURG 

The capital and principal city of the Alsace region in 

Eastern France and is the official seatof the European 

Parliament. Located close to the border with Germany, 

it is the capital oftheBas-Rhin département. The city 

and the region of Alsace are historically Germanspeaking, 

explaining the city's Germanic name. In 2006, 

the city proper had 272,975 inhabitants and its urban 

community 467,375 inhabitants. With 638,670 

inhabitants in 2006, Strasbourg's metropolitan area (aire 

urbaine) (only the part of the metropolitan area on 

French territory) is the ninth largest in France. The 

transnational Eurodistrict Strasbourg-Ortenau had a 

population of 884,988 inhabitants in 2008. 

Strasbourg is the seat of several European institutions, 

such as the Council of Europe (with its European Court 

of Human Rights, its European Directorate for the 

Quality of Medicines and its European Audiovisual 

Observatory) and the Eurocorps, as well as the 

European Parliament and the European Ombudsman of 

the European Union. The city is the seat of the Central 

Commission for Navigation on the Rhine. 

Strasbourg's historic city centre, the Grande Île (Grand 

Island) with Petite France, was classified a World 

Heritage site by UNESCO in 1988, the first time such an 

honour was placed on an entire city centre. Strasbourg 

is fused into the Franco-German cultureand although 

violently disputed throughout history, has been a bridge 

of unity between France and Germany for centuries, 

especially through the University of Strasbourg, 

currently the largest in France, andthecoexistenceof 

Catholic and Protestant culture. 

Economically, Strasbourg is an important centre of 

manufacturing and engineering, aswellasofroad, rail, 

and river communications. The port of Strasbourg is the 

second largest on the Rhine after Duisburg, Germany. In 

terms of city rankings, Strasbourg has been ranked third 

th 

in France and 18 globally for innovation. 

WEATHER 

Alsace is blessed with one of the lowest rainfalls in all 

France. 

AVERAGE VALUES IN SEPTEMBER Temperature 15,5 ºC 

Precipitation (mm) 55,5 

Average Wind (m/s) 2,6 

Cloud covering (in %) 56 

TIMEZONE 

Central European Time - GMT +1. 

USEFUL LINKS 

EDTNA/ERCA 

www.edtnaerca.org 

EDTNA/ERCA Conference Department 

www.czech-in.cz 

Strasbourg Convention Burreau 

www.mystrasbourg.com 

Comité Régional du Tourisme d'Alsace 

www.tourisme-alsace.com 

ST 


55

EDTNA/ERCA INTERNATIONAL CONFERENCE 2013 

nd 

We are pleased to announce that the 42 EDTNA/ERCA International Conference will be held after 26 years in 

Scandinavia, Sweden. 

MALMÖ -HOST CITY 2013 

Malmö is the commercial centre of southern Sweden and an international city. This is expressed, not least,bythefact 

thatMalmö has 300 000 residents from approximately 170 different nationalities. 

Malmö is also undergoing a transition from being an industrialcitytoa city of knowledge. Older industries have been 

replaced by investments in new technology and training programmes of high calibre. Malmö University, which opened 

in 1998, is Sweden's latest venture in the field of higher education, accommodating some 15.000 students. 

BASIC FACTS 

Founded: 1275 

Area: 

2 

158 km 

Population: 303,873 

Information: www.malmotown.com/en 


www.edtnaerca.org

STRASBOURG MAP 

Map of Strasbourg including hotels is on the next page. 

LEGEND 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

Strasbourg Convention ad Conference Centre - Conference Venue 

Boat trip - Departure 

Tram stations in the Conference venue vicinity ( Lycée Kléber, Wacken) 

Route from the Venue to the Boat trip departure 

Hilton Strasbourg 

Le JeanSebastianBach Hotel 

Sofitel Strasbourg 

HotalAdagio Strasbourg Place Kleber 

Europe Hotel 

Le Grand Hotel 

Hotel Maison Rouge 

Hotel Mercure Strasbourg Quartier Saint Jean 

Hotel Mercure Strasbourg Centre 

Hotel Mercure Strasbourg Gare Centrale 

Hotel Novotel Strasbourg Centre Halles 

ETC Hotel Strasbourg 

Hotel Ibis Strasbourg Centre Ponts Couverts

1 

2 

11 

3 

9 

4 

6 

10 

8 

7 

5 

12 

13

41 EDTNA/ERCA - 41st EDTNA/ERCA International Conference

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?